Curriculum Vitae and Bibliography Charanjit S. Rihal, MD ...
Curriculum Vitae and Bibliography
Charanjit S. Rihal, MD, BSc, BSc(Med), MBA
PERSONAL INFORMATION
| | |
|Place of Birth: |Nairobi |
| |Kenya |
| | |
|Citizenship: |United States |
| | |
|Work Address: |Mayo Clinic |
| |200 First Street SW |
| |Rochester, MN 55905 |
| | |
|Email Address: |rihal@mayo.edu |
PRESENT ACADEMIC RANK AND POSITION
| | |
|Consultant - Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, |07/01/1995 - Present |
|Rochester, Minnesota | |
| | |
|Director - Cardiac Catheterization Laboratory, Division of Cardiovascular Diseases, Department of|2003 - Present |
|Internal Medicine, Mayo Clinic, Rochester, Minnesota | |
| | |
|Professor of Medicine - College of Medicine, Mayo Clinic |10/01/2004 - Present |
| | |
|Chair - Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, |04/20/2010 - Present |
|Rochester, Minnesota | |
EDUCATION
| | |
|University of Manitoba |1978 - 1981 |
|BSc, Faculty of Science, Bachelor of Science | |
| | |
|University of Winnipeg |1981 - 1985 |
|MD, Faculty of Medicine, BSc (Med) | |
| | |
|University of Manitoba |1985 - 1986 |
|Internship, Special Mixed Medicine Internship | |
| | |
|Mayo Graduate School of Medicine, College of Medicine, Mayo Clinic |1986 - 1989 |
|Residency, Internal Medicine | |
| | |
|Mayo Graduate School of Medicine, College of Medicine, Mayo Clinic |1989 - 1992 |
|Fellowship, Cardiovascular Diseases | |
| | |
|Mayo Graduate School of Medicine, College of Medicine, Mayo Clinic |1992 - 1993 |
|Fellowship, Interventional Cardiology | |
| | |
|Carlson School of Management, University of Minnesota |1998 - 2000 |
|MBA, Carlson Executive MBA Program | |
| | |
|Additional Education | |
| | |
|Introductory Statistics |09/1989 - 12/1989 |
|Department of Health Sciences Research, Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|Clinical Trials Design and Conduct |08/1990 |
|Department of Health Sciences Research, Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|Introduction to Regression |01/1991 |
|Department of Health Sciences Research, Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|Survival Analysis |03/1991 |
|Department of Health Sciences Research, Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|Critical Appraisal of Statistical Methods in the Medical Literature |06/1991 |
|Department of Health Sciences Research, Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|Faculty, 14th Annual Practice of Internal Medicine |05/1993 |
|Section of Continuing Education, Mayo Clinic and Foundation | |
|Rochester, Minnesota | |
| | |
|Demonstrator, Mayo Interventional Practice - Advanced Laser Angioplasty and Atherectomy |05/1993 |
|Mayo Clinic and Foundation | |
|Rochester, Minnesota | |
| | |
|Faculty, Mayo Interventional Practice Symposium, Section of Continuing Education |06/1996 |
|Mayo Clinic and Foundation | |
|Rochester, Minnesota | |
| | |
|CI in Healthcare: The Six-Step Improvement Process |08/1996 |
|Management and Employee Education Program, Mayo Foundation | |
|Rochester, Minnesota | |
| | |
|Moving Forward, Mayo Conference on Quality |10/1996 |
|Mayo Foundation | |
|Rochester, Minnesota | |
| | |
|Advanced Management Program for Healthcare Executives |03/1998 - 04/1998 |
|University of Minnesota, Carlson School of Management | |
|Rochester, Minnesota | |
| | |
|Advanced Management Program for Healthcare Executives |04/1999 |
|University of Minnesota, Carlson School of Management | |
|Rochester, Minnesota | |
| | |
|ACC/SCA&I Board Review Program in Interventional Cardiology |08/1999 |
|American College of Cardiology | |
|San Francisco, California | |
| | |
|All Staff Leadership Program |01/2000 |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Advanced Issues in the Design and Conduct of Randomized Clinical Trials |06/2000 |
|9th International Symposium on Long-Term Clinical Trials | |
|Royal College of Physicians | |
|London, United Kingdom | |
| | |
|Healthcare Leadership Improvement Initiative |06/2000 |
|Mayo Clinic | |
|Rochester, Minnesota | |
BOARD CERTIFICATION(S)
| | |
|American Board of Internal Medicine (ABIM) | |
| | |
|Diplomate in Internal Medicine |1989 - Present |
| | |
|Diplomate in Internal Medicine |1991 - Present |
| | |
|Diplomate in Internal Medicine |1999 - Present |
| | |
|American Heart Association | |
| | |
|Basic Life Support (BLS) | |
| | |
|Advanced Cardiovascular Life Support (ACLS) | |
| | |
|College of Physicians and Surgeons of Ontario | |
| | |
|College of Physicians and Surgeons of Ontario | |
| | |
|National Board of Medical Examiners | |
| | |
|Diplomate |1987 - Present |
| | |
|Royal College of Physicians and Surgeons, Canada | |
| | |
|Internal Medicine |1990 - Present |
| | |
|Internal Medicine |1992 - Present |
LICENSURE
| | | |
|Ontario |62235 |07/1986 - 07/2005 |
| | | |
|Minnesota |30588 |11/1996 |
| | | |
|Arizona |25903 |12/1997 |
| | | |
|Florida |ME-0075040 |01/1998 |
| | | |
|Wisconsin |43146-020 |10/2000 |
HONORS/AWARDS
| | |
|President, Lord Selkirk Regional Comprehensive, High Student Council - Lord Selkirk Regional High|09/1977 - 06/1978 |
|School | |
| | |
|Dr. D. Patterson Memorial Fund - Bursary |06/1978 |
| | |
|Academic Honor List - Lord Selkirk Regional High School |06/1978 |
| | |
|Alumni Association Scholarship, High Standing - Faculty of Science, University of Manitoba |05/1980 |
| | |
|Dean's Honor List, Faculty of Science - University of Manitoba |06/1980 |
| | |
|Dean's Honor List, Faculty of Science - University of Manitoba |06/1981 |
| | |
|Dr. J.R.W. Nicholson Prize, Best B. S.c. (Med) Thesis - Faculty of Medicine, University of |06/1985 |
|Manitoba | |
| | |
|Outstanding Achievement Award, Internal Medicine Residency - Mayo Graduate School of Medicine, |05/1989 |
|College of Medicine, Mayo Clinic | |
| | |
|Outstanding Clinical Achievement Award for Subspecialty Trainee in Cardiovascular Diseases - Mayo|05/1993 |
|Graduate School of Medicine, College of Medicine, Mayo Clinic | |
| | |
|Individual Award for Excellence, Mayo Awards for Excellence - Mayo Clinic |07/1999 |
| | |
|Elected by his peers for inclusion in Best Doctors in America® |01/2007 - 01/2008 |
| | |
|Silver level certification of the Mayo Quality Fellows Program - Mayo Clinic Quality Academy, |03/04/2011 |
|Rochester, Minnesota | |
PREVIOUS PROFESSIONAL POSITIONS AND MAJOR APPOINTMENTS
| | |
|Instructor, Advanced Cardiac Life Support - Mayo Foundation for Medical Education and Research, |1987 - 1989 |
|Rochester, Minnesota | |
| | |
|Staff Cardiologist, Hamilton Civic Hospitals - Hamilton Civic Hospitals, Hamilton, Ontario, |1993 - 1995 |
|Canada | |
| | |
|Assistant Professor of Medicine, Division of Cardiology - McMaster University, Ontario, Canada |1993 - 1995 |
| | |
|Associate Director - Cardiology Training Program, McMaster University, Hamilton, Ontario, Canada |1995 |
| | |
|Assistant Professor of Medicine - College of Medicine, Mayo Clinic |07/01/1995 - 07/01/1999 |
| | |
|Associate Professor of Medicine - College of Medicine, Mayo Clinic |07/01/1999 - 10/01/2004 |
| | |
|Chair - Clinical Practice Committee, Division of Cardiovascular Diseases, Department of Internal |2002 - 2003 |
|Medicine, Mayo Clinic, Rochester, Minnesota | |
PROFESSIONAL & COMMUNITY MEMBERSHIPS, SOCIETIES AND SERVICES
| | |
| | |
|Professional Memberships & Services | |
| | |
| | |
|American Board of Internal Medicine | |
| | |
|Diplomate | |
| | |
| | |
|American College of Cardiology | |
| | |
|Fellow | |
| | |
|Cardiac Catheterization and Intervention Committee | |
| | |
|Member |01/2005 - Present |
| | |
|Coding and Nomenclature Committee | |
| | |
|Member |03/2001 - 01/2003 |
| | |
|Interventional Scientific Council | |
| | |
|Member |04/2011 - 03/2014 |
| | |
| | |
|American Heart Association | |
| | |
|Council on Clinical Cardiology | |
| | |
|Member | |
| | |
|International Committee | |
| | |
|Member |07/01/2011 - 06/30/2013 |
| | |
| | |
|Arteriocyte DSMB | |
| | |
|Chair | |
| | |
| | |
|BioMed Central | |
| | |
|Member |01/2000 - 12/2000 |
| | |
|Advisor |01/2000 - 12/2000 |
| | |
| | |
|Canadian Institutes of Health Research | |
| | |
|ResearchNet | |
| | |
|Member | |
| | |
| | |
|College of Physicians and Surgeons of Ontario | |
| | |
|Member | |
| | |
| | |
|Hamilton Civic Hospitals | |
| | |
|Ad Hoc Committee, Radiographic Equipment | |
| | |
|Member |01/1994 - 12/1994 |
| | |
| | |
|Heart Valve Society of America | |
| | |
|Therapeutic Interventions Council | |
| | |
|Member |08/2005 - Present |
| | |
| | |
|JACC Interventions | |
| | |
| | |
|Editorial Consultant |06/01/2010 - 05/31/2012 |
| | |
| | |
|Medical Research Council of Canada | |
| | |
|Reviewer | |
| | |
| | |
|Minnesota Medical Association | |
| | |
|Member | |
| | |
| | |
|National Institutes of Health | |
| | |
|Member |01/2000 |
| | |
|National Heart, Lung, and Blood Institute | |
| | |
|Member |01/2000 - 01/2003 |
| | |
|Bypass Angioplasty Revascularization Investigation | |
| | |
|Member |01/2000 - 01/2003 |
| | |
|NHLBI BARI & Dynamic Registry Data Comparison, Writing Group | |
| | |
|Member |01/2000 - 01/2003 |
| | |
| | |
|Royal College of Physicians and Surgeons of Canada | |
| | |
|Fellow | |
| | |
| | |
|Zumbro Valley Medical Society | |
| | |
|Member | |
JOURNAL RESPONSIBILITIES
| | |
| | |
|Journal Editorial Responsibilities | |
| | |
| | |
|Circulation: Cardiovascular Interventions | |
| | |
|Editorial Board Member, Boston, Maryland |03/15/2011 - 03/15/2013 |
| | |
| | |
|Evidence Based Cardiovascular Medicine | |
| | |
|Editorial Board Member |07/1997 - 01/2000 |
| | |
|Associate Editor |01/2001 - 01/2003 |
| | |
| | |
|International Journal of Cardiology | |
| | |
|Editorial Board Member |01/2006 |
| | |
| | |
|Journal Other Responsibilities | |
| | |
| | |
|Canadian Journal of Cardiology | |
| | |
|Reviewer | |
| | |
| | |
|Catheterization and Cardiovascular Diagnosis | |
| | |
|Reviewer | |
| | |
| | |
|Circulation | |
| | |
|Reviewer | |
| | |
| | |
|European Heart Journal | |
| | |
|Reviewer | |
| | |
| | |
|Evidence Based Cardiovascular Medicine | |
| | |
|Reviewer | |
| | |
| | |
|Heart | |
| | |
|Reviewer |01/2004 - Present |
| | |
| | |
|International Journal of Cardiology | |
| | |
|Reviewer |01/2006 |
| | |
| | |
|JACC: Cardiovascular Imaging | |
| | |
|Reviewer |01/2007 - Present |
| | |
| | |
|Journal of Evidence-Based Cardiovascular Medicine, Hamilton, Ontario | |
| | |
|Reviewer |07/1997 - Present |
| | |
| | |
|Journal of Interventional Cardiology | |
| | |
|Reviewer | |
| | |
| | |
|Journal of the American College of Cardiology | |
| | |
|Reviewer | |
| | |
| | |
|Journal of the American Medical Association | |
| | |
|Reviewer | |
| | |
| | |
|Mayo Clinic Proceedings | |
| | |
|Reviewer | |
EDUCATIONAL ACTIVITIES
Teaching
| | |
|Introductory Statistics |09/1989 - 12/1989 |
|Department of Health Sciences Research -HSR5823 | |
|Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|Clinical Trials Design and Conduct |08/1990 |
|Department of Health Sciences Research -HSR5837 | |
|Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|Introduction to Regression |01/1991 |
|Department of Health Sciences Research - HSR5827 | |
|Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|Survival Analysis |03/1991 |
|Department of Health Sciences Research -HSR5840 | |
|Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|Critical Appraisal of Statistical Methods in the Medical Literature |06/1991 |
|Department of Health Sciences Research | |
|Mayo Medical School | |
|Rochester, Minnesota | |
| | |
|14th Annual Practice of Internal Medicine, Section of Continuing Education |05/1993 |
|Faculty | |
|Mayo Clinic and Foundation | |
|Rochester, Minnesota | |
| | |
|Advanced Laser Angioplasty and Atherectomy (Demonstrator) |05/1993 |
|Mayo Interventional Practice | |
|Mayo Clinic and Foundation | |
|Rochester, Minnesota | |
| | |
|Mayo Interventional Practice Symposium, Section of Continuing Education |06/1996 |
|Faculty | |
|Mayo Clinic and Foundation | |
|Rochester, Minnesota | |
| | |
|CI in Healthcare: The Six-Step Improvement Process |08/1996 |
|Management and Employee Education Program | |
|Mayo Foundation | |
|Rochester, Minnesota | |
| | |
|Moving Forward, Mayo Conference on Quality |10/1996 |
|Mayo Foundation | |
|Rochester, Minnesota | |
| | |
|Adjunctive Pharmacological Therapy in Acute MI: ACE Inhibitors for All Patients? |02/1997 |
|Cardiology Today and Tomorrow | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Cardiac Physiology: Left Ventricular Systolic Function |09/1997 |
|Mayo Cardiovascular Review Course for Cardiology Boards and Recertification | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Systemic Defibrinogenation Prior to High-Risk PTCA |10/1997 |
|Cardiovascular Research Conference | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Transradial Intervention |10/1997 |
|Proctorship in New Interventional Strategies | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Current Invasive Techniques in the Management of Coronary Artery Disease -- Overview of |11/1997 |
|Interventional Cardiology | |
|Anesthesia Rounds | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Medical Decision Making: What is the Evidence? |12/1997 |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Stenting by Radial Approach |12/1997 |
|Cardiology Today and Tomorrow | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Advanced Management Program for Healthcare Executives |03/1998 |
|University of Minnesota, Carlson School of Management | |
|Rochester, Minnesota | |
| | |
|Is Urgent Intervention Required for Patients With Unstable Angina/Non Q-Wave Myocardial |05/1998 |
|Infarction? | |
|Cardiology Today and Tomorrow | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|The Effectiveness of Antiplatelet Therapy |06/1998 |
|Fifth Annual Mayo Interventional Cardiology Symposium | |
|Rochester, Minnesota | |
| | |
|Strategies for Treatment of Bifurcation Lesions |06/1998 |
|Fifth Annual Mayo Interventional Cardiology Symposium | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Expense and Quality Management in Coronary Angioplasty |11/1998 |
|Mayo Conference on Quality | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Indications for Myocardial Revascularization an Evidence Based Approach |12/1998 |
|Invited Speaker | |
|Two Days in Cardiology & Mayo Clinic Cardiology Conference | |
|Chiang Rai, Thailand | |
| | |
|Role of Inflammation, Infection in Atherosclerosis and Thrombosis |12/1998 |
|Invited Speaker | |
|Two Days in Cardiology & Mayo Clinic Cardiology Conference | |
|Chiang Rai, Thailand | |
| | |
|Advanced Management Program for Healthcare Executives |04/1999 |
|University of Minnesota, Carlson School of Management | |
|Rochester, Minnesota | |
| | |
|Percutaneous Balloon Valvuloplasty: The US Experience-Can Echo Predict the Result |06/1999 |
|Valvular Heart Disease, New Strategies for the Third Millennium | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|The Thrombotic Lesion |07/1999 |
|Mayo Interventional Cardiology Symposium | |
|Napa Valley, California | |
| | |
|ACC/SCA&I Board Review Program in Interventional Cardiology |08/1999 |
|American College of Cardiology | |
|San Francisco, California | |
| | |
|Cardiology Basics for Boards: Statistics and Ventricular Function |09/1999 |
|1999 Cardiovascular Board Review Course | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|All Staff Leadership Program |01/2000 |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Advanced Issues in the Design and Conduct of Randomized Clinical Trials |06/2000 |
|9th International Symposium on Long-Term Clinical Trials, Royal College of Physicians | |
|London, United Kingdom | |
| | |
|Healthcare Leadership Improvement Initiative |06/2000 |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Percutaneous Balloon Valvuloplasty: The US Experience - Can Echo Predict the Result |06/2000 |
|Valvular Heard Disease 2000: New Strategies for the Third Millennium | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Trouble with Access: What Should I Do When The Femorals Are Shot? |08/2000 |
|7th Annual Mayo Interventional Cardiology Symposium | |
|Napa Valley, California | |
| | |
|Statistics for the Cardiovascular Boards |09/2000 |
|Cardiovascular Board Review Course | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Treatment Strategies for Chronic Coronary Artery Disease: Medical Versus Surgical Intervention |09/2000 |
|Cardiovascular Board Review Course | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Hot Topics in Interventional Cardiology: Drive-by Shootings: Combining Coronary and Renal |12/2000 |
|Arteriography | |
|Cardiology Today and Tomorrow | |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Reimbursement & Coding Seminar for Cardiology |05/2001 |
|Minnesota Chapter of the American College of Cardiology | |
|Minneapolis, Minnesota | |
| | |
|Statistics for the Cardiovascular Boards |09/2001 - 10/2001 |
|2001 Cardiovascular Board Review Course for Cardiology Boards and Recertification | |
|Rochester, Minnesota | |
| | |
|Treatment Strategies for Chronic Artery Disease: Medical Versus Surgical Intervention |09/2001 - 10/2001 |
|2001 Cardiovascular Board Review Course for Cardiology Boards and Recertification | |
|Rochester, Minnesota | |
| | |
|Revenue Expansion, Service Excellence and Investment in Next-Generation Technologies |10/2001 |
|Cardiovascular Roundtable, 2001 National Membership Meeting | |
|Marina Del Rey, California | |
| | |
|Conflict Management Series Class |12/2001 |
|Mayo Clinic | |
|Rochester, Minnesota | |
| | |
|Statistics for the Cardiovascular Boards |09/2002 |
|7th Annual Mayo Clinic Cardiovascular Review Course for Cardiology Boards and Recertification | |
|Mayo School of Continuing Medical Education | |
|Rochester, Minnesota | |
| | |
|Treatment Strategies for Chronic Coronary Artery Disease: Medical Versus Surgical Intervention |09/2002 |
|7th Annual Mayo Cardiovascular Review Course for Cardiology Boards and Recertification | |
|Mayo School of Continuing Medical Education | |
|Rochester, Minnesota | |
| | |
|Case Presentation: 65-Year-Old Diabetic with Severe Chronic Stable Angina, 3-Vessel Disease, and |10/2002 |
|Normal Left Ventricular Function | |
|Mayo Clinic Update in Cardiovascular Disease | |
|Mayo School of CME | |
|Rochester, Minnesota | |
| | |
|Clinical Reviews - 2002, Diagnostic Test Ordering and Interpretation |11/2002 |
|Mayo School of Continuing Medical Education | |
|Rochester, Minnesota | |
| | |
|Coronary Artery Disease: Prevention, Detection & Treatment |2005 |
|Director | |
|Mayo Clinic College of Medicine | |
|Las Vegas, Nevada | |
| | |
|Mayo Interventional Cardiology Board Review Course |2005 |
|Director | |
|Mayo Clinic College of Medicine | |
|Rochester, Minnesota | |
| | |
|Patients |04/2005 |
|Mayo Clinical Exam Teaching Conference | |
|Rochester, Minnesota | |
| | |
|Busan Interveventional Cardiology Review Course |12/02/2005 |
|Co-Director | |
|Mayo Clinic College of Medicine | |
|Busan, North Korea | |
| | |
|Coronary Artery Disease:Prevention, Detection & Treatment |2006 |
|Director | |
|Mayo Clinic College of Medicine | |
|Las Vegas, Nevada | |
| | |
|Mayo Interventional Cardiology Board Review Course |2006 |
|Director | |
|Mayo Clinic College of Medicine | |
|Rochester, Minnesota | |
| | |
|Coronary Artery Disease: Prevention, Detection & Treatment |2007 |
|Director | |
|Mayo Clinic College of Medicine | |
|Las Vegas, Nevada | |
| | |
|Mayo Interventional Cardiology Board Review Course |2007 |
|Director | |
|Mayo Clinic College of Medicine | |
|Rochester, Minnesota | |
| | |
|Coronary Artery Disease: Prevention, Detection & Treatment |2008 |
|Director | |
|Mayo Clinic College of Medicine | |
|Las Vegas, Nevada | |
| | |
|Mayo Interventional Cardiology Board Review Course |2008 |
|Director | |
|Mayo Clinic College of Medicine | |
|Rochester, Minnesota | |
| | |
|Vulnerable Plaque/Vulnerable Patient |07/24/2009 - 07/26/2009 |
|Director | |
|Cardiology Updates in Sedona: A Weekend Review, Mayo Clinic | |
|Sedona, Arizona | |
Mentorship
| | |
|Goraya, Tauqir Y (Fellow) |1999 - 2001 |
| | |
|Haley, John H (Fellow) |1999 - 2001 |
| | |
|Nkomo, Vuyisile T (Fellow) |1999 - 2001 |
| | |
|Orford, James (Fellow) |2001 - 2002 |
| | |
|Powell, Brian (Fellow) |2001 - 2003 |
| | |
|Hilliard, Anthony (Cardiology Fellow) |2007 |
| | |
|Motiei, Arashk (Cardiology Fellow) |2007 |
Scholarship
Presentations
| | |
|STEMI Interventions - The Great Debates: Which Stent to Use in Primary PCI? - DES is the way to |02/2009 |
|go | |
|LUMEN | |
|Miami Beach, Florida | |
| | |
|STEMI Processes Symposium: The World's Best - The Mayo Clinic |02/2009 |
|LUMEN | |
|Miami Beach, Florida | |
Honors and Awards for Education
| | |
|Internal Medicine Trainee Award, Outstanding Teaching - Mayo Graduate School of Medicine, College|05/1991 |
|of Medicine, Mayo Clinic | |
| | |
|Outstanding Teacher of the Year Award - Division of Cardiovascular Diseases, Department of |01/1997 |
|Internal Medicine, Mayo Clinic | |
| | |
|Outstanding Teacher of the Year Award - Division of Cardiovascular Diseases, Department of |01/1998 |
|Internal Medicine, Mayo Clinic | |
| | |
|Outstanding Teacher of the Year Award - Division of Cardiovascular Diseases, Department of |01/1999 |
|Internal Medicine, Mayo Clinic | |
| | |
|W. Proctor Harvey, M.D., Young Teacher Award - American College of Cardiology |10/1999 |
| | |
|Outstanding Teacher of the Year Award - Division of Cardiovascular Diseases, Department of |01/2000 |
|Internal Medicine, Mayo Clinic | |
| | |
|Outstanding Teacher of the Year Award - Division of Cardiovascular Diseases, Department of |01/2002 |
|Internal Medicine, Mayo Clinic | |
| | |
|Outstanding Teacher of the Year Award - Division of Cardiovascular Diseases, Department of |01/2003 |
|Internal Medicine, Mayo Clinic | |
| | |
|Outstanding Teacher of the Year Award - Division of Cardiovascular Diseases, Department of |01/2004 |
|Internal Medicine, Mayo Clinic | |
| | |
|Outstanding Teacher in Physical Diagnosis given by Internal Medicine Residents - Mayo Clinic |08/2006 |
| | |
|Internal Medicine Residency Program Teacher of the Year - Mayo Clinic |01/2007 - 01/2008 |
INSTITUTIONAL/DEPARTMENTAL ADMINISTRATIVE RESPONSIBILITIES, COMMITTEE MEMBERSHIPS AND OTHER ACTIVITIES
| | |
| | |
|Mayo Clinic | |
| | |
| | |
|Bypass Angioplasty Revascularization Investigation 2 - Diabetes | |
| | |
|Member |2005 - Present |
| | |
|Publications Committee | |
| | |
|Member |2005 - Present |
| | |
| | |
|Department of Education Services | |
| | |
|Member |01/1990 - 12/1990 |
| | |
|College of Medicine, Mayo Clinic | |
| | |
|Mayo Graduate School of Medicine | |
| | |
|Member |01/1990 - 12/1990 |
| | |
|Department of Internal Medicine | |
| | |
|Division of Cardiology | |
| | |
|Member |01/1990 - 12/1990 |
| | |
|Education Committee | |
| | |
|Member |01/1990 - 12/1990 |
| | |
|Fellows' Representative |07/1990 - 06/1992 |
| | |
| | |
|Mayo Foundation for Medical Education and Research | |
| | |
|Catheterization Laboratory Education Committee | |
| | |
|Member |01/2001 - 01/2003 |
| | |
| | |
|Mayo Clinic Task Forces | |
| | |
|Catheterization Laboratory Continuous Improvement Study Group | |
| | |
|Member |01/2000 - 12/2000 |
| | |
| | |
|Mayo Group Practices | |
| | |
|Cardiac Cath Supply Expense Management Group | |
| | |
|Chair |01/1998 - 12/1998 |
| | |
|Member |01/1998 - 12/1998 |
| | |
|DRG 104-107, Expense Management Group | |
| | |
|Member |01/1997 - 12/1997 |
| | |
|Hospital Formulary Advisory Group | |
| | |
|Member |01/1997 - 12/1997 |
| | |
|NHLBI BARI & Dynamic Registry Data Comparison Writing Group | |
| | |
|Member |01/2000 - 12/2000 |
| | |
| | |
|Mayo Clinic in Rochester | |
| | |
| | |
|Department of Internal Medicine | |
| | |
|Member |01/1996 - 12/1996 |
| | |
|Division of Cardiovascular Diseases | |
| | |
|Member |01/1997 - 12/1997 |
| | |
|Cardiac Catheterization Laboratory | |
| | |
|Member |01/1997 - Present |
| | |
|Cath Pack Task Force | |
| | |
|Chair |01/1998 - 01/1999 |
| | |
|Member |01/1998 - 01/1999 |
| | |
|Clinical Practice Committee | |
| | |
|Chair |01/1997 - 01/2001 |
| | |
|Member |01/1997 - 01/2001 |
| | |
|Continuous Improvement Study Group | |
| | |
|Member |01/2000 - 12/2000 |
| | |
|Education Committee | |
| | |
|Member |01/2000 - 12/2000 |
| | |
|Supply Expense Management Group | |
| | |
|Chair |01/1998 - 01/1999 |
| | |
|Member |01/1998 - 01/1999 |
| | |
|Cardiovascular Division Formulary Subcommittee | |
| | |
|Chair |01/2002 - 01/2003 |
| | |
|Member |01/2002 - 12/2003 |
| | |
|Clinical Practice Committee | |
| | |
|Chair |01/2002 - 12/2003 |
| | |
|Clinical Practice Working Group | |
| | |
|Vice Chair |01/2001 - 01/2002 |
| | |
|Member |01/2001 - 01/2002 |
| | |
|DRG 104-107, Expense Management Group | |
| | |
|Member |01/1997 - Present |
| | |
|DRG 112 Expense Management Group | |
| | |
|Chair |01/1996 - 12/1997 |
| | |
|Member |01/1996 - 12/1997 |
| | |
|Operations Committee | |
| | |
|Member |01/2001 - 12/2001 |
| | |
| | |
|Hospital Formulary Advisory Group | |
| | |
|Member |01/1997 - 12/1997 |
| | |
| | |
|Mayo Clinic Rochester Committees | |
| | |
|Clinical Practice Committee - Rochester | |
| | |
|Member |01/2006 - Present |
| | |
|Mayo Clinic Pharmacy and Therapeutics Committee | |
| | |
|Member |01/2001 - 12/2003 |
| | |
| | |
|Mayo Clinic Rochester Workgroups | |
| | |
|Patient Identification Workgroup | |
| | |
|Chair | |
| | |
|Universal Protocol Workgroup | |
| | |
|Chair |01/2004 |
| | |
| | |
|Saint Marys Hospital | |
| | |
|Member |01/1997 - 12/1997 |
| | |
|Cardiology Inpatient Practice Oversight Committee | |
| | |
|Member |01/1997 - 12/1997 |
PRESENTATIONS
| | |
|National | |
| | |
|Epidemiology and Economics of Coronary Artery Disease |10/22/2010 |
|Coronary Artery Disease: Prevention, Detection, and Treatment | |
|Las Vegas, Nevada | |
| | |
|Stent Thrombosis and Drug Interactions |10/23/2010 |
|Coronary Artery Disease: Prevention, Detection, and Treatment | |
|Las Vegas, Nevada | |
| | |
|Is There Any Role Left For PCI in Stable CAD? |10/23/2010 |
|Coronary Artery Disease: Prevention, Detection, and Treatment | |
|las Vegas, Nevada | |
| | |
|Acute Coronary Artery Disease & Coronary Artery Disease |10/23/2010 |
|Coronary Artery Disease: Prevention, Detection, and Treatment | |
|Las Vegas, Nevada | |
| | |
|What To Do With the Stent Patient Needing Non-Cardiac Surgery |10/24/2010 |
|Coronary Artery Disease: Prevention, Detection, and Treatment | |
|Las Vegas, Nevada | |
INVITED PRESENTATIONS AND VISITING PROFESSORSHIPS
| | |
|Invited Presentations | |
| | |
|Management of Acute Myocardial Infarction |04/1995 |
|Swiss Cardiac Society Symposium | |
|Lugano, Switzerland | |
| | |
|Revascularization for Acute Coronary Syndromes |09/1995 |
|Cardiology Update '95: The Angina Continuum | |
|Muskoka, Ontario, Canada | |
| | |
|PTCA Prior to Non-Cardiac Surgery |10/1995 |
|Waterloo County Critical Care Journal Club | |
|Waterloo, Ontario, Canada | |
| | |
|Risk Assessment in Patients Undergoing Vascular Surgery |09/1997 |
|2nd International Symposium on Perioperative Cardiac Care | |
|Tel Aviv, Israel | |
| | |
|Role of Coronary Revascularization Prior to Non-Cardiac Surgery |09/1997 |
|2nd International Symposium on Perioperative Cardiac Care | |
|Tel Aviv, Israel | |
| | |
|The Role of CABG or PTCA Prior to Non-Cardiac Surgery |01/1998 |
|16th Annual Symposium: Clinical Update in Anesthesiology and Advances in Techniques of | |
|Cardiopulmonary Bypass | |
|San Juan, Puerto Rico | |
| | |
|Can the New York Model Predict Angioplasty Complications in Other Databases? |10/1998 |
|2nd International Congress on Coronary Artery Disease | |
|Florence, Italy | |
| | |
|Revascularization for Chronic Coronary Artery Disease, An Evidence Based Approach |01/1999 |
|Interventional Cardiology, Controlling Costs & Improving Outcomes | |
|Cambridge Health Resources | |
|Orlando, Florida | |
| | |
|ACC National Cardiovascular Data Registry: Facing the New Millennium (fireside panel) |03/1999 |
|American College of Cardiology 48th Annual Scientific Session | |
|New Orleans, Louisiana | |
| | |
|DRG Expense Management: Achieving Results |05/1999 |
|The 13th Annual TSI User and Educational Conference | |
|San Francisco, California | |
| | |
|Controlling Costs and Improving Outcomes |01/2000 |
|2nd Annual Interventional Cardiology | |
|Los Angeles, California | |
| | |
|2nd Annual Interventional Cardiology: Controlling Costs & Improving Outcomes |01/2000 |
|Cambridge Health Resources | |
|Los Angeles, California | |
| | |
|How to Practice Outcome-Based Medicine |02/2000 |
|The 5th Annual Cardiology at Cancun 2000 | |
|Cancun, Mexico | |
| | |
|The Radial Artery Approach to Coronary Intervention |02/2000 |
|The 5th Annual Cardiology at Cancun 2000 | |
|Cancun, Mexico | |
| | |
|Acute Coronary Syndromes: Management Strategies for the New Millennium |02/2000 |
|The 5th Annual Cardiology at Cancun 2000 | |
|Cancun, Mexico | |
| | |
|Clinical Decision Making (Special Sessions) |03/2000 |
|49th Annual Scientific Session of the American College of Cardiology | |
|Anaheim, California | |
| | |
|Mitral Valvuloplasty and Alcohol Ablation of HOCM |03/2000 |
|Live Demonstrations from Catheterization Laboratory, Mayo Clinic, Rochester | |
|49th Annual Scientific Session of the American College of Cardiology | |
|Anaheim, California | |
| | |
|Role of Echocardiography in the Catheterization Laboratory |03/2000 |
|Live Demonstrations from Catheterization Laboratory, Mayo Clinic, Rochester | |
|49th Annual Scientific Session of the American College of Cardiology | |
|Anaheim, California | |
| | |
|Live Demonstrations from Catheterization Laboratory, Mayo Clinic Rochester |03/2000 |
|49th Annual Scientific Session of the American College of Cardiology | |
|Anaheim, California | |
| | |
|Case Presentation: Multivessel, Endstage Disease and Management |10/2000 |
|Interventional Cardiology: 2000 and Beyond | |
|Minneapolis, Minnesota | |
| | |
|Preoperative Evaluation |01/2001 |
|Kuwait Cardiac Society | |
|Kuwait | |
| | |
|Modern Treatment of Unstable Angina |01/2001 |
|Kuwait Cardiac Society | |
|Kuwait | |
| | |
|Revascularization for Chronic Coronary Artery Disease |01/2001 |
|Kuwait Cardiac Society | |
|Kuwait | |
| | |
|Perioperative Cardiac Care |02/2001 |
|The 3rd International Symposium on Perioperative Cardiac Care - A Joint Anesthesiology-Cardiology| |
|Symposium | |
|Tel Aviv, Israel | |
| | |
|Preoperative Cardiovascular Testing |03/2001 |
|International Medical Conference, Indraprastha Apollo Hospitals | |
|New Delhi, India | |
| | |
|Incidence and Prognostic Importance of Worsening Renal Function Following Percutaneous Coronary |03/2001 |
|Interventional Procedures | |
|American College of Cardiology 50th Annual Scientific Session | |
|Orlando, Florida | |
| | |
|Session 2: Second Complication Case Presentations Session. Introduction lecture: Economic |06/2001 |
|Implications of Complications | |
|Third International Congress on Complications During Coronary Interventions: Prevention & | |
|Management | |
|Lausanne, Switzerland | |
| | |
|Frontiers in Cardiovascular Health |07/2001 |
|XVII World Congress of the International Society for Heart Research | |
|Winnipeg, Manitoba, Canada | |
| | |
|Current Role of Percutaneous Mitral Valvuloplasty for Treatment of Rheumatic Mitral Stenosis |07/2001 |
|XVII World Congress of the International Society for Heart Research | |
|Winnipeg, Manitoba, Canada | |
| | |
|Managing Quality and Costs in a Rapidly Changing Interventional Practice |07/2001 |
|International Academy of Cardiology 2nd International Congress on Heart Disease - New Trends in | |
|Research, Diagnosis, and Treatment | |
|Washington, District of Columbia | |
| | |
|Case and Discussion: Alternative and Novel Vascular Approaches to the PCI Patient |09/2001 |
|Intervention USA | |
|Minneapolis, Minnesota | |
| | |
|Revenue Expansion, Service Excellence, and Investment in Next-Generation Technologies |10/2001 |
|Cardiovascular Roundtable 2001 National Membership Meeting | |
|Marina del Rey, California | |
| | |
|New Devises in PCI - A War Against Restenosis: "Drug Eluting Stents" |12/2001 |
|53rd Annual Conference of the Cardiological Society of India | |
|Hyderabad, India | |
| | |
|The Role of PTCA and CABG Prior to Non-Cardiac Surgery |02/2002 - 03/2002 |
|Mayo Clinic Symposium on Anesthesia and Perioperative Medicine | |
|Grand Bahama Island, Bahamas | |
| | |
|Stable Ischemic Syndrome I: Advances in Diagnosis Between |03/2002 |
|Oral Contributions | |
|The American College of Cardiology's 51st Annual Scientific Session | |
|Atlanta, Georgia | |
| | |
|Baseline Risk Predicts Therapeutic Efficacy Difference Between Coronary Artery Bypass and |03/2002 |
|Coronary Angioplasty | |
|The American College of Cardiology's 51st Annual Scientific Session | |
|Atlanta, Georgia | |
| | |
|Innovative Assessment and Modulation of Ischemia |04/2002 |
|The 66th Annual Scientific Meeting of the Japanese Circulation Society | |
|Sapporo, Japan | |
| | |
|Cost and Quality Management Amidst Rapidly Changing Practice Paradigms |04/2002 |
|The 2nd Biannual Mayo Clinic Update in Primary Care | |
|Riyadh, Saudi Arabia | |
| | |
|Management of the Diabetic Patient with Coronary Artery Disease: Current Issues |04/2002 |
|The 2nd Biannual Mayo Clinic Update in Primary Care | |
|Riyadh, Saudi Arabia | |
| | |
|The Evolving Role of Myocardial Revascularization in Patients with Diabetes Mellitus |04/2002 |
|The 66th Annual Scientific Meeting of the Japanese Circulation Society | |
|Sapporo, Japan | |
| | |
|Cardiovascular Management of the Patient with Diabetes Mellitus |04/2002 |
|Fellow's Conference, St. Marys Hospital | |
|Rochester, Minnesota | |
| | |
|Perioperative Management of the Cardiac Patient |05/2002 |
|Mayo Clinic Perioperative Medicine Symposium | |
|Beijing, People's Republic of China | |
| | |
|Is Balloon Valvuloplasty Indicated in Asymptomatic Patients with MS |06/2002 |
|Valvular Heart Disease: New Strategies for the Third Millenium | |
|Rochester, Minnesota | |
| | |
|Statistics for Cardiovascular Boards |09/21/2002 |
|7th Annual Mayo Clinic Cardiovascular Review Course of Cardiology Boards and Recertification | |
|Rochester, Minnesota | |
| | |
|Treatment Strategies for Chronic Coronary Artery Disease: Medical Versus Surgical Intervention |09/21/2002 |
|7th Annual Mayo Clinic Cardiovascular Review Course of Cardiology Boards and Recertification | |
|Rochester, Minnesota | |
| | |
|Case Presentation: 65-Year-Old Diabetic with Severe Chronic Stable Angina, 3-Vessel Disease, |10/2002 |
|Normal Left Ventricular Function | |
|Mayo Clinic Update in Cardiovascular Diseases | |
|Rochester, Minnesota | |
| | |
|Case Presentation: 65-year-old Diabetic with Severe Chronic Stable Angina, 3-Vessel Disease, and|10/26/2002 |
|Normal Left Ventricular Function | |
|Mayo Clinic Update in Cardiovascular Disease | |
|Rochester, Minnesota | |
| | |
|Managing Patients with Ischemic Heart Disease |02/2003 |
|Lecture III | |
|35th Annual Scientific Meeting of Mayo Clinic-Thai Heart Cardiovascular Conference | |
|Phuket, Thailand | |
| | |
|Bifurcation Lesions, BIg Vessels, and Drug Eluting Stents |02/2003 |
|PCI Conference | |
|35th Annual Scientific Meeting of Mayo Clinic-Thai Heart Cardiovascular Conference | |
|Phuket, Thailand | |
| | |
|Nonfemoral Access: Pearls for Success |03/2003 |
|Meet the Experts Symposium | |
|American College of Cardiology's 52nd Annual Scientific Session | |
|Chicago, Illinois | |
| | |
|Outpatient Angiography: In and Our of the Door |03/2003 |
|Symposium | |
|American College of Cardiology's 52nd Annual Scientific Session | |
|Chicago, Illinois | |
| | |
|Cardiac Risk Assessment Before Noncardiac Surgery |03/2003 |
|Brown-Bag Lunchtime Panels | |
|American College of Cardiology's 52nd Annual Scientific Session | |
|Chicago, Illinois | |
| | |
|Clinical and Economic Implications of Drug-Eluting Stents |05/2003 |
|Cardiovascular Grand Rounds, Michigan Heart and Vascular Institute | |
|Ann Arbor, Michigan | |
| | |
|Heart Disease and Diabetes |07/2003 |
|Advances and Changing Trends in Medicine | |
|Orlando, Florida | |
| | |
|The Changing Role of Anti Platelet Therapy |07/2003 |
|Advances and Changing Trends in Medicine | |
|Orlando, Florida | |
| | |
|Advances in Percutaneous Coronary Interventions |10/04/2003 |
|Advances and Controversies in Cardiology Practice | |
|Mexico City, Mexico | |
| | |
|Session 2: Expanding Role of Cardiac MR and EBCT |01/25/2004 |
|8th Biennial International Andreas Gruentzig Society (IAGS) | |
|Lana'i, Hawaii | |
| | |
|Session 14: Percutaneous Valve Repair or Replacement |01/25/2004 |
|8th Biennial International Andreas Gruentzig Society (IAGS) | |
|Lana'i, Hawaii | |
| | |
|Impaired Coronary Microcirculation Evidenced by Abnormal Thrombolysis in Myocardial Infarction |03/07/2004 |
|Frame Counts in Patients with Transient Left Ventricular Apical Ballooning Syndrome | |
|ACC 2004 | |
|New Orleans, Louisiana | |
| | |
|Percutaneous Coronary Intervention |03/08/2004 |
|ACC 2004 | |
|New Orleans, Louisiana | |
| | |
|Transient Left Ventricular Apical Ballooning Syndrome: A US Case-Series |03/08/2004 |
|ACC 2004 | |
|New Orleans, Louisiana | |
| | |
|Vascular Access Site Complications Post Percutaneous Coronary Intervention. |03/08/2004 |
|ACC 2004 | |
|New Orleans, Louisiana | |
| | |
|Myocardial Bridging is Associated with Impairment in Endothelium-Dependent Vasorelaxation |03/08/2004 |
|ACC 2004 | |
|New Orleans, Louisiana | |
| | |
|Echocardiographic Diastolic Function Grade Accurately Reflects Changes in Ventricular Wall Stress|03/08/2004 |
|and Stiffness. | |
|ACC 2004 | |
|New Orleans, Louisiana | |
| | |
|Eptifibatide and Abciximab were Equivalent as Adjunctive Therapy for Percutaneous Coronary |09/30/2004 |
|Intervention (PCI) in a Large Unselected Population with ST Elevation Myocardial Infarction | |
|(STEMI). | |
|Washington, District of Columbia | |
| | |
|Case Selection Session |10/02/2004 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Statistics for the Cardiovascular Boards |10/02/2004 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Procedural Techniques Session - Drug Eluting Stents |10/02/2004 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Case Selection: Introduction |10/02/2004 |
|9th Annual Mayo CV Review Course for Cardiology Boards and Recertification | |
|Rochester, Minnesota | |
| | |
|Treatment Strategies for Chronic Coronary Artery Disease: Medical Versus Surgical Intervention. |10/02/2004 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Statistics for the Cardiovascular Board |10/02/2004 |
|9th Annual Mayo CV Review Course for Cardiology Boards and Recertification | |
|Rochester, Minnesota | |
| | |
|Procedural Techniques: Drug Eluting Stents |10/02/2004 |
|9th Annual Mayo CV Review Course for Cardiology Boards and Recertification | |
|Rochester, Minnesota | |
| | |
|Treatment Strategies for Chronic Coronary Artery Disease: Medical versus Surgical Intervention |10/03/2004 |
|9th Annual Mayo CV Review Course for Cardiology Boards and Recertification | |
|Rochester, Minnesota | |
| | |
|50-Year Old Male with Atrial Fibrillation and Congestive Heart Failure. |11/06/2004 |
|Panel Review | |
|AHA 2004 | |
|New Orleans, Louisiana | |
| | |
|55-year-old Female with Severe Angina, Poor LV Dysfunction and Non-revascularization |11/06/2004 |
|Panel Review | |
|AHA 2004 | |
|New Orleans, Louisiana | |
| | |
|Percutaneous Mitral Annuloplasty in Experimental Heart Failure: Acute and Chronic Efficacy and |11/06/2004 |
|Safety (2069). | |
|AHA 2004 | |
|New Orleans, Louisiana | |
| | |
|Cell Therapies for Cardiac Repair: Case Presentations and Panel Review |11/06/2004 |
|The New Biology and Novel Therapeutics: From Bench to Bedside | |
|New Orleans, Louisiana | |
| | |
|Mitral Regurgitation and LV Dysfunction: Role of Percutaneous Approaches |11/06/2004 |
|The New Biology and Novel Therapeutics: From Bench to Bedside | |
|New Orleans, Louisiana | |
| | |
|New Insights and Therapies for Congestive Heart Failure: Case Presentations and Panel Review |11/06/2004 |
|The New Biology and Novel Therapeutics: From Bench to Bedside | |
|New Orleans, Louisiana | |
| | |
|Quality and Cost Management |01/26/2005 |
|MUSC Heart Center Grand Rounds | |
|Charleston, South Carolina | |
| | |
|Quality and Cost Management |01/27/2005 |
|MUSC Heart Center Grand Rounds | |
|Charleston, South Carolina | |
| | |
|Role of PCI |02/14/2005 |
|The 10th Annual Cardiology at Cancun 2005 | |
|Cancun, Mexico | |
| | |
|Ischemic Heart Disease I |02/14/2005 |
|Panel: Drs. Bell, Rihal, Harrington and Sundt; Reeder is moderator | |
|The 10th Annual Cardiology at Cancun 2005 | |
|Cancun, Mexico | |
| | |
|Lysis Versus PCI: Transfer Strategies |02/14/2005 |
|The 10th Annual Cardiology at Cancun 2005 | |
|Cancun, Mexico | |
| | |
|Ischemic Heart Disease II |02/16/2005 |
|Panel: Drs. Harrington, Bell, Rihal, and Gau; Reeder is moderator | |
|The 10th Annual Cardiology at Cancun 2005 | |
|Cancun, Mexico | |
| | |
|Percutaneous Valve Repair/Replacement: Current Status |02/16/2005 |
|The 10th Annual Cardiology at Cancun 2005 | |
|Cancun, Mexico | |
| | |
|Percutaneous Intervention |03/06/2005 |
|ACC 2005 | |
|Orlando, Florida | |
| | |
|Acute Coronary Syndrome, Percutaneous Revascularization with Drug-Eluting Stent or Point of |03/06/2005 |
|Service. IIB/IIA, aspirin, Clopidogrel, Ticlopidine, Heparin, Warfarin, and Many More. How Long| |
|and What to do if Patient Requires Noncardiac Surgery and ... | |
|ACC 2005 | |
|Orlando, Florida | |
| | |
|Percutaneous Valve Procedures |03/07/2005 |
|ACC 2005 | |
|Orlando, Florida | |
| | |
|Management of Patient with a Small Aortic Valve Area |03/08/2005 |
|ACC 2005 | |
|Orlando, Florida | |
| | |
|Ischemic Heart Disease |05/2005 |
|Chairs, Bell and Rihal | |
|Yonsei-Mayo Cardiology Symposium | |
|North Korea | |
| | |
|Percutaneous Coronary Intervention – Current State of the Art |05/2005 |
|Yonsei-Mayo Cardiology Symposium | |
|North Korea | |
| | |
|New Frontiers in Interventional Cardiology |05/13/2005 |
|Yonsei-Mayo Cardiology Symposium | |
|North Korea | |
| | |
|Drug – Eluting Stents: Promises and Limitations |05/27/2005 |
|16th Annual Scientific Mtg of the Puerto Rico Chapter of ACC | |
|San Juan, Puerto Rico | |
| | |
|Percutaneous Catheter-based Approaches to Heart Valve Disease |05/27/2005 |
|16th Annual Scientific Mtg of the Puerto Rico Chapter of ACC | |
|San Juan, Puerto Rico | |
| | |
|The hemodynamic perspective. |06/22/2005 |
|6th International Congress on Complications during Coronary Intervention: | |
|Management and Prevention | |
|Lausanne, Switzerland | |
| | |
|Cordis Symposium: DES in specific lesion subsets. |06/22/2005 |
|Chair | |
|6th International Congress on Complications during Coronary Intervention: | |
|Management and Prevention | |
|Lausanne, Switzerland | |
| | |
|Complication cases. Transthoracic management of acute myocardial infarction: clinical acumen |06/22/2005 |
|verus guidelines. | |
|Case Presentation | |
|6th International Congress on Complications during Coronary Intervention: | |
|Management and Prevention | |
|Lausanne, Switzerland | |
| | |
|New Frontiers in Interventional Cardiology |09/09/2005 |
|Grand Rounds, Baylor | |
|Houston, Texas | |
| | |
|Basic Science Conference; Percutaneous Transvenous Mitral Annuloplasty for Mitral Regurgitation |09/09/2005 |
|Associated with Heart Failure | |
|Grand Rounds, Baylor | |
|Houston, Texas | |
| | |
|Lesion Subsets: PCI in ACS |09/24/2005 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Optional Simulation Session |09/24/2005 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Statistics for the CV Boards |09/24/2005 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Procedural Tools Segment: Drug-Eluting Stents |09/24/2005 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Lesion Subsets: Bifurcations and Ostial Disease |09/24/2005 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Non-Coronary Interventions: Valvular Interventions |09/24/2005 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Recognizing and Managing Complications - My Top 10 Rules for Success in PCI |09/24/2005 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Treatment Strategies for Chronic Coronary Artery Disease: Medical Versus Surgical Intervention |09/24/2005 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Advances in Cardiac Interventional Radiological Procedures: An Update for Anesthesia Providers |10/13/2005 |
|Mayo Clinic Seminar for Nurse Anesthetists | |
|Rochester, Minnesota | |
| | |
|Revascularization Decisions in Complex Lesions and Patients. |10/16/2005 |
|TCT 2005 | |
|Washington, District of Columbia | |
| | |
|Structural Heart Disease: Diagnosis and Interventional Approaches |10/16/2005 |
|Live Case Discussant | |
|TCT 2005 | |
|Washington, District of Columbia | |
| | |
|Bifurcation disease – interventional approaches, devices and strategies |10/16/2005 |
|Live Case Dialogues II, Session I. | |
|TCT 2005 | |
|Washington, District of Columbia | |
| | |
|Masters Course in Complex Coronary and Peripheral Intervention. Live Case – Session 3, Coronary |10/16/2005 |
|(Structural) Cases | |
|Live Case Discussant | |
|TCT 2005 | |
|Washington, District of Columbia | |
| | |
|Special considerations for intervention in the patient with bifurcation disease with and without |10/16/2005 |
|left main involvement: A case-based review. | |
|TCT 2005 | |
|Washington, District of Columbia | |
| | |
|Approaches to the Non-revascularization Patient. |11/12/2005 |
|Mayo Sponsored AHA Symposium | |
|Dallas, Texas | |
| | |
|82 year old with anterior STEMI, PPCI 6 hours after symptom onset. |11/12/2005 |
|Case Presentation and Panel Review. Panel: Drs. Gersh, Holmes, Reeder. | |
|Mayo Sponsored AHA Symposium | |
|Dallas, Texas | |
| | |
|Case Presentation and Panel Review: 66-year-old with anterior STEMI, PPCI 6 hours after Symptom |11/12/2005 |
|Onset | |
|Rihal is the presenter. Panel is Drs. Gersh, Holmes, Reeder | |
|The New Biology and Novel Therapeutics: From Bench to Bedside | |
|Dallas, Texas | |
| | |
|Frontiers in Interventional Cardiology |12/02/2005 |
|Busan | |
|Busan, North Korea | |
| | |
|Status of LMCA PCI in 2006 |02/07/2006 |
|1st Gulf Interventional Meeting | |
|Dubai, United Arab Emirates | |
| | |
|Valvular Heart Disease, Interventional Approaches |02/07/2006 |
|1st Gulf Interventional Meeting | |
|Dubai, United Arab Emirates | |
| | |
|Bifurcation Practical Tips and Tricks |02/08/2006 |
|1st Gulf Interventional Meeting | |
|Dubai, United Arab Emirates | |
| | |
|Live Case Transmission Session VI |03/13/2006 |
|ACC 2006 | |
|Atlanta, Georgia | |
| | |
|Assessment of severity of mitral regurgitation |03/13/2006 |
|ACC 2006 | |
|Atlanta, Georgia | |
| | |
|New Issues in Valve Disease |03/14/2006 |
|ACC 2006 | |
|Atlanta, Georgia | |
| | |
|Alcohol Ablation; Patient Selection and Technique |05/12/2006 |
|SCAI | |
|Chicago, Illinois | |
| | |
|Mitral and Tricuspid Session: Mitral Annuloplasty I |05/14/2006 |
|Valvular Heart Disease 2006 | |
|Las Vegas, Nevada | |
| | |
|Aortic and Pulmonary Session: Periprosthetic Regurgitation |05/14/2006 |
|Valvular Heart Disease 2006 | |
|Las Vegas, Nevada | |
| | |
|Challenge to US Adoption of the Transradial Technique |10/22/2006 |
|Section-Transradial Access and Intervention: An Edited Case Instructional Series | |
|TCT | |
|Washington, District of Columbia | |
| | |
|Controversies in ACS, AMI and PCI Treatment Pathways: Challenges for the Guidelines |10/23/2006 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Drug-eluting Stents: Complex Cases Emphasizing Advanced Techniques and Procedural Strategy I |10/23/2006 |
|Case presentation | |
|TCT | |
|Washington, District of Columbia | |
| | |
|PCI using the Tandem Heart |11/11/2006 |
|Panel: Drs. Holmes, Schaff, Bell, Sundt | |
|AHA | |
|Chicago, Illinois | |
| | |
|Chronic CAD: Middle aged diabetic male undergoing a knee replacement |11/11/2006 |
|In conjunction w/Drs. Holmes, Rihal, Bell, Prasad | |
|AHA | |
|Chicago, Illinois | |
| | |
|Percutaneous valve repair/replacement in mitral valve disease. Is it ready for prime time? |11/19/2006 |
|Sights & Sounds of Cardiology | |
|Cruise | |
| | |
|Charisma, acuity, typhoon |11/20/2006 |
|Sights & Sounds of Cardiology | |
|Cruise | |
| | |
|Coronary Artery Disease: To Intervene or Not to Intervene |11/20/2006 |
|Sights & Sounds of Cardiology | |
|Cruise | |
| | |
|State-of-the-art STEMI and NSTEMI: Guidelines into clinical practice |11/20/2006 |
|Sights & Sounds of Cardiology | |
|Cruise | |
| | |
|Antithrombotic therapy in ACS. Who, when, how long. What to do before |11/20/2006 |
|Sights & Sounds of Cardiology | |
|Cruise | |
| | |
|Antithrombotic therapy in ACS. Who, when, how long. What to do before elective surgery? |11/20/2006 |
|Sights & Sounds of Cardiology | |
|Cruise | |
| | |
|State-of-the-art: Stents: current status. Bare metal stents for whom? Where are we headed? |11/20/2006 |
|Sights & Sounds of Cardiology | |
|Cruise | |
| | |
|Clinical Coroner: Multivessel disease and PCI – illustrative examples to demonstrate the value |11/20/2006 |
|of PCI. | |
|Sights & Sounds of Cardiology | |
|Cruise | |
| | |
|Percutaneous Treatment of Heart Valve Disease: Fantasy or Reality? |12/07/2006 |
|Grand Rounds | |
|Toledo, Ohio | |
| | |
|Workshop - Topic 1) Overcoming the last frontier of coronary intervention; bifurcation, LM, CTO. |01/19/2007 |
|2) Educational disaster in the cath lab. 3) Handling antiplatelets after DES. 4) Long-term | |
|results: bare stents vs. DES. | |
|East Meets West - Thai Heart Conference | |
|Petchaburi, Thailand | |
| | |
|Reperfusion therapy for acute myocardial infarction: the best possible strategies in the real |01/20/2007 |
|world practice. | |
|East Meets West - Thai Heart Conference | |
|Petchaburi, Thailand | |
| | |
|Beyond drug eluting stent: aiming towards ideal biological modulation of the vessel wall and its |01/20/2007 |
|potential therapeutic application | |
|East Meets West - Thai Heart Conference | |
|Petchaburi, Thailand | |
| | |
|How do you benchmark your outcome? |03/24/2007 |
|ACC 2007 | |
|New Orleans, Louisiana | |
| | |
|Update on BARI 2D: what we hope to learn |03/24/2007 |
|ACC 2007 | |
|New Orleans, Louisiana | |
| | |
|Percutaneous valve repair and replacement |03/29/2007 |
|Grand Rounds - Desert Cardiology Center | |
|Rancho Mirage, California | |
| | |
|Drug-eluting stents, current status, future directions |03/29/2007 |
|Grand Rounds - Annenberg Center | |
|Palm Desert, California | |
| | |
|Percutaneous valve repair and replacement |03/30/2007 |
|Grand Rounds - Annenberg Center | |
|Palm Desert, California | |
| | |
|Advances in interventional cardiology |06/01/2007 |
|Mayo Turkey | |
|Maslak, Turkey | |
| | |
|ACS: latest management strategies |06/02/2007 |
|Mayo Turkey | |
|Maslak, Turkey | |
| | |
|Drug coating stents vs. bare metal stents: current status |06/02/2007 |
|Mayo Turkey | |
|Maslak, Turkey | |
| | |
|Combined coronary and renal artery intervention: where are we heading? |06/19/2007 |
|Mayo International Vascular Symposium | |
|Reykjavik, Iceland | |
| | |
|Cardiovascular outcomes following vascular intervention: the case of EVAR |06/19/2007 |
|Mayo International Vascular Symposium | |
|Reykjavik, Iceland | |
| | |
|The radial artery: unconditionally! |06/21/2007 |
|Coronary Intervention: Management & Prevention | |
|Lausanne, Switzerland | |
| | |
|Mayo rounds in Lausanne - percutaneous valve interventions: fantasy or reality? |06/22/2007 |
|Coronary Intervention: Management & Prevention | |
|Lausanne, Switzerland | |
| | |
|Welcome & course overview |09/10/2007 |
|CAD | |
|Las Vegas, Nevada | |
| | |
|Pharmacol invasive approach for ACS |09/11/2007 |
|CAD | |
|Las Vegas, Nevada | |
| | |
|Illustrative cases: hybrid procedures, supported PCI |09/11/2007 |
|CAD | |
|Las Vegas, Nevada | |
| | |
|Epidemiologic trends and the patients of the future |09/12/2007 |
|CAD | |
|Las Vegas, Nevada | |
| | |
|Antiplatelet therapy for ACS |10/06/2007 |
|Michigan ACC Chapter Meeting | |
|Traverse City, Michigan | |
| | |
|What you need to know about drug-eluting stents |10/06/2007 |
|Michigan ACC Chapter Meeting | |
|Traverse City, Michigan | |
| | |
|Clinical dilemmas in cardiology |11/04/2007 |
|AHA | |
|Orlando, Florida | |
| | |
|Antiplatelet therapy in PCI |11/05/2007 |
|AHA | |
|Orlando, Florida | |
| | |
|An Interventional Perspective |12/10/2007 |
|Cardiovascular Update | |
|Dubai, United Arab Emirates | |
| | |
|The COURAGE Trial: An Interventional Perspective |12/10/2007 |
|Cardiovascular Update | |
|Dubai, United Arab Emirates | |
| | |
|Takatsubo revisited: scope of problem and management: the Mayo Clinic experience |12/10/2007 |
|Cardiovascular Update | |
|Dubai, United Arab Emirates | |
| | |
|Drug-eluting stents and the problem of late thrombosis: can it be avoided? Non-cardiac surgery |12/10/2007 |
|after recent stent placement: what to do? | |
|Cardiovascular Update | |
|Dubai, United Arab Emirates | |
| | |
|Novel techniques in percutaneous valve repair/replacement |12/11/2007 |
|Cardiovascular Update | |
|Dubai, United Arab Emirates | |
| | |
|PCI: Quo Vadis? |02/29/2008 |
|Grand Rounds | |
|Houston, Texas | |
| | |
|High Risk Supported PCI |03/08/2008 |
|Konyang Mayo Cardiology Conference | |
|Konyang, South Korea | |
| | |
|Drug Eluting Stents – Where do we go from here? |03/08/2008 |
|Konyang Mayo Cardiology Conference | |
|Konyang, South Korea | |
| | |
|Multi-Vessel Disease |03/30/2008 |
|Co-Chair | |
|ACC/ISIC/SCAI | |
|Chicago, Illinois | |
| | |
|Late Stent Thrombosis: Fact or Fiction |03/30/2008 |
|ACC/ISIC/SCAI | |
|Chicago, Illinois | |
| | |
|BMS vs. DES Session: Cardiac Care Team Interventional Spotlight: Advanced Track |03/30/2008 |
|ACC/ISIC/SCAI | |
|Chicago, Illinois | |
| | |
|Periprosthetic Regurgitation |05/05/2008 - 07/2008 |
|VHD | |
|Las Vegas, Nevada | |
| | |
|Percutaneous Mitral Annuloplasty I |05/05/2008 - 07/2008 |
|VHD | |
|Las Vegas, Nevada | |
| | |
|PCI Complications-Cine Review #2 |06/13/2008 |
|11th Live Symposium of Complex Coronary & Cardiovascular Cases in New York | |
|New York, New York | |
| | |
|Multivessel Disease Trials |06/14/2008 |
|11th Live Symposium of Complex Coronary & Cardiovascular Cases in New York | |
|New York, New York | |
| | |
|Septal Ablation for HOCM |06/26/2008 |
|AICT | |
|Bangkok, Thailand | |
| | |
|Use of Percutaneous LVAD for High-Risk PCI Support |06/27/2008 |
|AICT | |
|Bangkok, Thailand | |
| | |
|Percutaneous Heart Valve Treatment: Fantasy or Reality |06/27/2008 |
|AICT | |
|Bangkok, Thailand | |
| | |
|Introduction and Topic Overview |09/19/2008 |
|Interventional Cardiology Board Review | |
|Rochester, Minnesota | |
| | |
|Epidemiology and Economics of CAD |09/19/2008 |
|Interventional Cardiology Board Review | |
|Rochester, Minnesota | |
| | |
|Simulation Session |09/20/2008 |
|Interventional Cardiology Board Review | |
|Rochester, Minnesota | |
| | |
|Valvular Interventions |09/20/2008 |
|Interventional Cardiology Board Review | |
|Rochester, Minnesota | |
| | |
|Left Main and Bifurcations |09/20/2008 |
|Interventional Cardiology Board Review | |
|Rochester, Minnesota | |
| | |
|Statistics for the Cardiovascular Boards in 40 Minutes or Less |09/20/2008 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Revascularization for Chronic Coronary Disease |09/21/2008 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Test Questions: Revascularization for Chronic Coronary Disease |09/21/2008 |
|CV Board Review | |
|Rochester, Minnesota | |
| | |
|Imaging for Coronary Artery Disease |10/06/2008 |
|Coronary Artery Disease: Prevention, Detection & Treatment | |
|Las Vegas, Nevada | |
| | |
|Hemodynamic support |10/07/2008 |
|Coronary Artery Disease: Prevention, Detection & Treatment | |
|Las Vegas, Nevada | |
| | |
|Special Case Presentation in Stable CAD |10/07/2008 |
|Coronary Artery Disease: Prevention, Detection & Treatment | |
|Las Vegas, Nevada | |
| | |
|Apical Ballooning Syndrome: A New Acute Cardiac Syndrome |10/07/2008 |
|Coronary Artery Disease: Prevention, Detection & Treatment | |
|Las Vegas, Nevada | |
| | |
|The stent patient needing non-cardiac surgery |10/08/2008 |
|Coronary Artery Disease: Prevention, Detection & Treatment | |
|Las Vegas, Nevada | |
| | |
|A new era in treating coronary artery disease: pushing boundaries with drug-eluting balloon |01/21/2010 |
|Invited by the Ministry of Health of Singapore as a visiting foreign expert in the area of heart | |
|disease at the National University Hospital. | |
|Singapore | |
| | |
|and tricks: top 10 practical tips on how to percutaneously close the periprosthetic valvular |01/22/2010 |
|regurgitation | |
|Invited by the Ministry of Health of Singapore as a visiting foreign expert in the area of heart | |
|disease at the National University Hospital. | |
|Singapore | |
| | |
|STEMI Interventions: Therapeutics, Logistics, and Politics |02/25/2010 |
|LUMEN 2010 | |
|Miami, Florida | |
| | |
|The Great Debates: Which Stent to Use in Primary PCI? DES is the way to go |02/26/2010 |
|LUMEN 2010 | |
|Miami, Florida | |
| | |
|STEMI Processes Symposium: Global Insights – The Mayo Clinic Experience |02/26/2010 |
|LUMEN 2010 | |
|Miami, Florida | |
| | |
|Update of the BARI 2D Aging Study |03/03/2010 - 03/05/2010 |
|AHA 50th Cardiovascular Disease Epidemiology and Prevention Conference | |
|San Francisco, California | |
| | |
|Device/Coil Closure of Prosthetic Paravalvular Leak |03/13/2010 |
|ACC | |
|Atlanta, Georgia | |
| | |
|Hybrid Suites: Opening New Doors to the Future |03/14/2010 |
|ACC | |
|Atlanta, Georgia | |
| | |
|Challenging Cases and Complications |03/15/2010 |
|Case presentation and discussion | |
|ACC | |
|Atlanta, Georgia | |
| | |
|Adult Congenital Heart Disease: ASD/PFO |03/15/2010 |
|ACC | |
|Atlanta, Georgia | |
| | |
|i2 Live Cases entitled Live Case Session 5: Structural |03/15/2010 |
|ACC | |
|Atlanta, Georgia | |
| | |
|Closure of Paravalvular Leaks |03/16/2010 |
|ACC | |
|Atlanta, Georgia | |
| | |
|Case Session |04/16/2010 |
|Valves in the Heart of the Big Apple | |
|New York City, New York | |
| | |
|Case/Oral presentations |04/16/2010 |
|Valves in the Heart of the Big Apple | |
|New York City, New York | |
| | |
|Call for complications |05/27/2010 |
|EuroPCR | |
|Paris, France | |
| | |
|Critical role of IMPELLA cardiac support in patients with hemodynamic compromise |05/27/2010 |
|EuroPCR | |
|Paris, France | |
| | |
|Live Case Presentations 21 & 22 |06/18/2010 |
|Thirteenth Annual Live Symposium of Complex Coronary & Vascular Cases | |
|New York City, New York | |
| | |
|Live Case Presentations 12, 13, & 14 |06/18/2010 |
|Thirteenth Annual Live Symposium of Complex Coronary & Vascular Cases | |
|New York City, New York | |
| | |
|Interventional Debates #3: Evolving Trends – STEMI Interventions / DES is preferred |06/18/2010 |
|Thirteenth Annual Live Symposium of Complex Coronary & Vascular Cases | |
|New York City, New York | |
| | |
|Case Presentation #3 |06/23/2010 |
|C3 | |
|Baltimore, Maryland | |
| | |
|Live Case Transmission #21 |06/23/2010 |
|C3 | |
|Baltimore, Maryland | |
| | |
|Plenary Session VI: Complex Lesion Subset |06/23/2010 |
|C3 | |
|Baltimore, Maryland | |
| | |
|Live Case Presentation #18: High Risk PCI |06/23/2010 |
|C3 | |
|Baltimore, Maryland | |
| | |
|How can Impella Device Improve Outcomes in STEMI PCI? |06/23/2010 |
|C3 | |
|Baltimore, Maryland | |
| | |
|Practical Utilization of Impella Device in Real-World Scenarios (Part 1 |06/23/2010 |
|C3 | |
|Baltimore, Maryland | |
| | |
|Complications Sessions |07/30/2010 |
|CICT | |
|San Francisco, California | |
| | |
|A Paravalvular Leak Procedure Complication (Case Presentation) |07/30/2010 |
|CICT | |
|San Francisco, California | |
| | |
|Case Presentation #2 (The Edward Sapian Valve) |07/31/2010 |
|CICT | |
|San Francisco, California | |
| | |
|Percutaneous Closure of Peri-valvular Leaks: Devices and Approaches Case-based Lecture |07/31/2010 |
|CICT | |
|San Francisco, California | |
| | |
|The Evolution of the Management of STEMI in 2010: The Mayo Clinic Experience |09/17/2010 |
|2nd Annual Acute Myocardial Update: Big 10 Topics in STEMI Management 2010 | |
|Columbus, Ohio | |
| | |
|Beyond PFO: Other Adult Structural Interventions |09/21/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Coronary AV Fistula Interventions: Two Case Presentations |09/21/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Paravalvular Leaks: Leak Mechanisms, Hemodynamics, and Hemolysis |09/21/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Essentials of Valvular Heart Disease Intervention: Hemodynamic Assessment and Interventional |09/21/2010 |
|Approaches with Approved Devices | |
|TCT | |
|Washington, District of Columbia | |
| | |
|Therapies for Mitral Stenosis – The “Forgotten” Disease |09/22/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Hybrid Coronary Revascularization - Background and Results |09/23/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Management Strategies in the Patient Needing Surgery: Theory and Evidence |09/23/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Hybrid Coronary Revascularization: The Rationale – Combining the Best of Both Worlds? |09/23/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Plenary Session XIX. Live Case Session VI. |09/24/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Device Closure of Aortic and Mitral Paravalvular Regurgitation |09/24/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Variability of Clopidogrel Response: Genetics, Drug Interactions, and More |09/24/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Imaging Assessment and Guidance: What the Interventional Needs to Know About Paravalvular Leaks |09/24/2010 |
|TCT | |
|Washington, District of Columbia | |
| | |
|Most Important Publications of the Last Year: Circulation: Cardiovascular Interventions Editors' |09/24/2010 |
|Choices | |
|TCT | |
|Washington, District of Columbia | |
| | |
|Revascularization for the diabetic patient: insights from BARI, BARI 2D, COURAGE, and SYNTAX |10/14/2010 |
|Great Innovations in Cardiology | |
|Tornio, Italy | |
| | |
|Case presentation – Paravalvular leak |10/15/2010 |
|Great Innovations in Cardiology | |
|Torino, Italy | |
| | |
|Focus on left atrial appendage closure in patients with AF |10/15/2010 |
|Great Innovations in Cardiology | |
|Torino, Italy | |
| | |
|Patient selection for transcatheter aortic valve implantation |10/15/2010 |
|Great Innovations in Cardiology | |
|Torino, Italy | |
| | |
|New hemodynamic support options for cardiogenic shock |10/17/2010 |
|First Collaborative Cardiac Mayo-Sheba Symposium | |
|Tel Aviv, Israel | |
| | |
|Imaging of Coronary Artery Disease Beyond Lumenography |11/14/2010 |
|AHA | |
|Chicago, Illinois | |
| | |
|Repairing a Paravalvular Leak |11/15/2010 |
|AHA | |
|Chicago, Illinois | |
| | |
|Management of Diabetic Vascular Diseases beyond BARI |01/22/2011 |
|Frontiers | |
|Cork, Ireland | |
| | |
|Percutaneous Valve Repair/Replacement: Hybrid Procedures |02/03/2011 |
|A Case Based Approach to Controversies in Cardiovascular Disease | |
|Dubai, United Arab Emirates | |
| | |
|Modern PCI Should Be the First Option for Revascularization |02/03/2011 |
|A Case Based Approach to Controversies in Cardiovascular Disease | |
|Dubai, United Arab Emirates | |
| | |
|PCI is Better Than Medical Management |02/04/2011 |
|A Case Based Approach to Controversies in Cardiovascular Disease | |
|Dubai, United Arab Emirates | |
| | |
|“What Troubles the 50+ Woman’s Heart?” |02/08/2011 |
|Media Briefing “In the Prime of Her Life – an Update on Women and Cardiovascular Disease.” | |
|New York City, New York | |
| | |
|Indications, techniques, and outcomes of percutaneous paravalvular leak closure |02/11/2011 |
|JIM - Joint Interventional Meeting | |
|Rome, Italy | |
| | |
|Live Demonstration, Commentator |03/12/2011 |
|KMT | |
|Seoul, South Korea | |
| | |
|Live case demonstration, Senior operator |03/12/2011 |
|KMT | |
|Seoul, South Korea | |
| | |
|Indications and Outcomes of Transcutaneous Aortic Valve Implantation (TAVI) |03/12/2011 |
|KMT | |
|Seoul, South Korea | |
| | |
|Visiting Professorships | |
| | |
|Kuwait Cardiac Society |2001 |
|Kuwait | |
| | |
|Cardiology Grand Rounds, Speaking on "Intercoronary Stent Patient Who Requires Noncardiac |02/25/2010 |
|Surgery" | |
|Mount Sinai | |
|Miami, Florida | |
| | |
|Board Review Course, Lecture entitled: Management of Multivessel Disease: Trials & Guidelines |06/19/2010 |
|Mount Sinai | |
|New York City, New York | |
| | |
|Grand Rounds, “Hemodynamic Support Options for Shock and High Risk PCI” |09/17/2010 |
|Ohio State University | |
|Columbus, Ohio | |
CLINICAL PRACTICE, INTERESTS, AND ACCOMPLISHMENTS
Interventional cardiology, new device therapies, treatment of acute myocardial infarction, structural heart disease
Management of acute coronary syndromes
cardiac hemodynamics
Cardiac management of patients undergoing noncardiac surgery
Cost structures and expense/practice management of cardiac catheterization laboratories.
RESEARCH INTERESTS
Population-based epidemiology and clinical trials in coronary artery disease
Combined coronary-peripheral vascular disease
Evaluation of new interventional therapies
Novel approaches to anti-thrombotic therapy in coronary artery disease
RESEARCH GRANTS AWARDED
Active Grants
Industry
| | | |
|Program Director / |A Randomized, Controlled Trial of the Medtronic Endeavor Drug (ABT-578) |12/2005 - 12/2011 |
|Principal Investigator |Eluting Coronary Stent System versus the Taxus Paclitaxel-Eluting | |
| |Coronary Stent System in the De Novo Native Coronary Artery Lesions | |
| |(ENDEAVOR IV Trial) (IRB 933-05). Funded by Medtronic Vascular. | |
| |(ENDEAVOR IV Trial) | |
| | | |
|Program Director / |CardiacAssist TandemHeart Registry. Funded by Cardiac Assist |05/2007 - 05/2009 |
|Principal Investigator |Technologies. | |
| | | |
|Program Director / |PARTNER - CV Surgery Cost Share Budget in: THE PARTNER TRIAL: Placement |09/2008 - 08/2013 |
|Principal Investigator |of AoRTic TraNscathetER Valves Trial. Funded by Edwards Life Sciences. | |
| |(2006-06-US) | |
| | | |
|Program Director / |PARTNER - CV Cath Lab Cost Share Budget in: THE PARTNER TRIAL: Placement|09/2008 - 08/2013 |
|Principal Investigator |of AoRTic TraNscathetER Valves Trial. Funded by Edwards Life Sciences. | |
| |(2006-06-US) | |
| | | |
|Program Director / |Placement of Aortic Transcatheter Valves Trial in: THE PARTNER TRIAL: |09/2008 - 08/2013 |
|Principal Investigator |Placement of AoRTic TraNscathetER Valves Trial. Funded by Edwards Life | |
| |Sciences. (2006-06-US) | |
| | | |
|Program Director / |USPELLA registry. Funded by ABIOMED. |07/2009 - 07/2010 |
|Principal Investigator | | |
| | | |
|Program Director / |The PARTNER II Trial: Placement of Aortic Transcatheter Valves Trial. |04/2011 - 04/2016 |
|Principal Investigator |Funded by Edwards Life Sciences. (PARTNER II Study No. 2010-12) | |
| | | |
|Program Director / |PREVAIL Prospective Randomized EVAluation of the WATCHMAN LAA Closure |06/2011 - 06/2018 |
|Principal Investigator |Device In Patients with Atrial Fibrillation Versus Long Term Warfarin | |
| |Therapy (PREVAIL). Funded by Atritech, Inc. (PREVAIL) | |
| | | |
|Co-Investigator |Low Molecular Weight Heparin Prior to Non-Cardiac Surgeries in Patients |01/1997 - 07/2007 |
| |with Mechanical Prosthetic Heart Valves. Funded by Rhone-Poulenc Rorer. | |
| |(Project Code #RP 54563) | |
| | | |
|Co-Investigator |Synergy Between PCI with TAXUS and Cardiac Surgery (SYNTAX Trial) (IRB |07/2005 - 07/2011 |
| |1268-05). Funded by Boston Scientific Corporation. (SYNTAX STUDY) | |
| | | |
|Co-Investigator |SATURN in: Study of Coronary Atheroma by InTravascular Ultrasound: |12/2008 - 11/2011 |
| |Effect of Rosuvastatin verses Atorvastatin. Funded by AstraZeneca | |
| |Pharmaceuticals LP. (D356IC00001) | |
| | | |
|Co-Investigator |A Clinical Evaluation of the Medtronic Endeavor® Resolute |02/2009 - 02/2015 |
| |Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo | |
| |Lesions in Native Coronary Arteries with a Reference Vessel Diameterof | |
| |2.25 mm to 4.2 mm. Funded by Medtronic Vascular. (RESOLUTE US Clinical | |
| |Trial) | |
| | | |
|Co-Investigator |A 104 week, randomized, double-blind, placebo-controlled, |06/2009 - 05/2012 |
| |parallel-group, multi-center study to evaluate the efficacy of aliskiren| |
| |onthe progression of atherosclerosis in patients with coronary artery | |
| |disease when added to optimal backround therapy. Funded by Novartis. | |
| |(SPP100A 2366) | |
| | | |
|Co-Investigator |A randomized, double-blind, placebo-controlled study to evaluate the |08/2009 - 07/2011 |
| |safety of 12 weeks in: SOLSTICE: A randomized, double-blind, | |
| |placebo-controlled study to evaluate the safety of 12 weeks. Funded by | |
| |GlaxoSmithKline. (PM1111810 / SOLSTICE) | |
| | | |
|Co-Investigator |DAPT Dual Antiplatelet Therapy Study. Funded by Harvard Clinical |04/2010 - 03/2014 |
| |Research Institute. (DAPT / Study IDE #G080186) | |
Completed Grants
Federal
| | | |
|Principal Investigator |Festival - Mayo Clinical Trial Site. Funded by National Institutes of |01/1997 - 01/1998 |
| |Health. (ICOS 3) | |
| | | |
|Principal Investigator |Mechanisms of Pro-Thrombosis in Diabetes Mellitus. Funded by National |07/2001 - 06/2005 |
| |Heart, Lung, and Blood Institute. (R01 HL 69146) | |
| | | |
|Program Director / |BARI 2 Diabetes (BARI 2D) Data Coordinating Center. Funded by National |06/2008 - 05/2009 |
|Principal Investigator |Heart, Lung, and Blood Institute. (U01 HL61744) | |
| | | |
|Co-Program Director / |BARI 2 Diabetes (BARI 2D) Data Coordinating Center. Funded by National |11/2000 - 05/2008 |
|Principal Investigator |Heart, Lung, and Blood Institute. (U01 HL61744) | |
| | | |
|Co-Investigator |Bypass angioplasty revascularization investigator (BARI II) trial. | |
| |Funded by National Heart, Lung, and Blood Institute. | |
Foundation
| | | |
|Principal Investigator |ABIM Medical Simulation Study. Funded by American Board of Internal |08/2004 - 08/2005 |
| |Medicine. (ABIM #2) | |
Industry
| | | |
|Principal Investigator |Evaluation of Reo-Pro and Stenting to Eliminate Restenosis (ERASER). |03/1996 - 08/1997 |
| |Funded by Eli Lilly And Company. (Lilly 39) | |
| | | |
|Principal Investigator |Genetic Analysis of Complex Human Traits: Application to Premature |07/1996 - 06/1998 |
| |Atheroscierotic Heart Disease. Funded by Gene Quest. (Gene 1) | |
| | | |
|Principal Investigator |A Phase III Randomized Comparative Trial of Hirudine Versus Heparin and |10/1996 - 09/1997 |
| |Warfarin Versus Standard Therapy for Acute Myocardial Ischemia Without | |
| |ST Elevation (OASIS). Funded by Behringwerke Ag. (Behring 1) | |
| | | |
|Principal Investigator |The CADILLAC Trial. Funded by Advanced Cardiovascular Systems, |10/1997 - 09/1999 |
| |Incorporated. (ACS 25) | |
| | | |
|Program Director / |EVENT REGISTRY: A Multicenter Registry for the Evaluation of Drug |07/2004 - 01/2010 |
|Principal Investigator |Eluting Stents and Ischemic Events. Funded by Millennium | |
| |Pharmaceuticals, Inc. (EVENT Registry) | |
| | | |
|Program Director / |COMPETENT Trial: A Pilot Safety Study of the Carillon Mitral Contour |09/2005 - 09/2011 |
|Principal Investigator |System for the Treatment of Mitral Regurgitation (CVP-0855-01, Revision | |
| |AA: December 31, 2004) (IRB 1098-05). Funded by Cardiac Dimensions, Inc.| |
| |(CARDIAC #19; 1A5785) | |
| | | |
|Program Director / |RESISTOR: Research Evaluation to Study Individuals who Show Thromboxane |02/2006 - 02/2009 |
|Principal Investigator |Or P2Y12 Receptor Resistance. Funded by University Hospitals of | |
| |Cleveland. (RESISTOR; site 013) | |
| | | |
|Program Director / |Recover II Budget in: RECOVER II Trial: A Prospective Randomized Trial |01/2009 - 12/2009 |
|Principal Investigator |Investigating the Use of the IMPELLA® RECOVER® LP 2.5 System in Patients| |
| |with Acute Myocardial Infarction Induced Hemodynamic Instability. Funded| |
| |by ABIOMED. (IDE Number: G080021) | |
| | | |
|Program Director / |FACILITATED ANTEGRADE STEERING TECHNIQUE IN CHRONIC TOTAL OCCLUSIONS |06/2009 - 05/2010 |
|Principal Investigator |(FAST-CTOs) CLINICAL STUDY. Funded by BridgePoint Medical, Inc. | |
| | | |
|Co-Investigator |Low molecular weight heparin prior to noncardiac surgeries in patients |01/1997 |
| |with pre-existing mechanical heart valves. Funded by Rhone-Poulenc | |
| |Rorer. | |
| | | |
|Co-Investigator |Effect of Chronic Percutaneous Mitral Annuloplasty on Mitral |11/2002 - 10/2004 |
| |Regurgitation in a Canine Model of Dilated Cardiomyopathy. Funded by | |
| |Cardiac Dimensions, Inc. (CARDIAC #18, 1A4582) | |
| | | |
|Co-Investigator |A Phase III International, Multi-Center, Prospective, Randomized, |07/2005 - 03/2007 |
| |Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy| |
| |of Nitric Oxide Synthase Inhibition with Tilarginine Acetate | |
| |Injection...(TRIUMPH Trial) IRB 1150-05. Funded by Arginox | |
| |Pharmaceuticals, Inc. (ARGINOX #3; 1A5716) | |
| | | |
|Co-Investigator |CHAMPION: CardioMEMS Heart Sensor Allows Monitoring of Pressure to |03/2009 - 03/2013 |
| |Improve Outcomes in NYHA Class III heart failure patients. Funded by | |
| |CardioMEMS, Inc. (CHAMPION CM-06-04) | |
Mayo Clinic
| | | |
|Program Director / |The Role of Platelet Reactivity in the Pathogenesis of Acute Coronary |05/2007 - 04/2010 |
|Principal Investigator |Syndromes. Funded by CR Protocol Program (Incl CR5 and CR10). | |
| | | |
|Co-Investigator |Low Molecular Weight Heparin Prior to Non-Cardiac Surgeries in Patients |06/1997 - 05/1999 |
| |with Mechanical Prosthetic Heart Valves. Funded by CR Programs. | |
| | | |
|Co-Investigator |Pilot Study: "Role of Endothelin in Microvascular Dysfunction Following |04/2005 - 04/2011 |
| |Percutaneous Coronary Intervention for Non ST Elevation MI.". Funded by | |
| |Mayo Clinic. | |
| | | |
|Co-Investigator |Does Chronic Rosiglitazone Therapy Improve Endothelial Function and |10/2005 - 09/2009 |
| |Preserve Renal Function in Non-Diabetic Patients with Chronic Kidney | |
| |Disease? Funded by Mayo CR20 Funding. | |
| | | |
|Co-Investigator |Incremental Prognostic Value of Comorbidity, Frailty, and Health-Related|10/2005 - 01/2009 |
| |Quality of life Measures on the In-hospital and One-Year Outcome | |
| |Following Percutaneous Coronary Interventions. Funded by Mayo CR20 | |
| |Funding. | |
| | | |
|Co-Investigator |Improved Coronary Endothelial Function following conversion to Sirolimus|04/2006 - 03/2009 |
| |in Cardiac Transplant Recipients. Funded by Mayo CR20 Funding. | |
| | | |
|Co-Investigator |Remote Myocardial Ischemic Preconditioning in Humans. Funded by CR |10/2006 - 09/2008 |
| |Programs. | |
PATENTS
| | | | |
|Title |Patent number |Date filed |Date issued |
| | | | |
|Devices and Methods for Crossing Chronic Total Occlusions. |US 12302142 |11/24/2008 |10/28/2009 |
|Patent Pending. No patent number or patent issue date as of yet. | | | |
|Filed 11/24/2008. Application received 10/28/2009. | | | |
|Inventors: Gupreet S. Sandhu, Charanjit S. Rihal | | | |
OTHER
| | |
|Making sense of stents: Physicians debate the benefits and risks. |06/29/2007 |
|Newspaper Publication Date: 29-JUN-07 Author: Tasker, Fred | |
| | |
| | |
|Miami Herald | |
|Miami, Florida | |
| | |
|The High Price of a Broken Heart |09/2007 |
|Quotes: The heart is the honorary seat of emotion—and no wonder. Experience, mood, temperament, | |
|and thought style can profoundly alter the ticker. Dispatches from the hidden superhighway | |
|between heart and mind. | |
|By: A.J.S. Rayl Jul/Aug 2007 | |
|Last Reviewed 25 Sep 2007 | |
|Article ID: 4361 | |
| | |
| | |
|Psychology Today Magazine | |
| | |
|Interview: What Is A Cardiac Catheterization, What Does It Show My Doctor, And What Are The |02/2008 |
|Dangers? | |
|February 7, 2008 | |
|ABC News | |
| | |
|Medtronic is in a stent sprint: The medical device maker has begun one of the biggest launches in|02/2008 |
|its history with approval of its drug-coated heart stent, Endeavor | |
|By JANET MOORE Last update: February 1, 2008 - 11:08 PM | |
| | |
| | |
|StarTribune | |
|Minneapolis, Minnesota | |
| | |
|Interview: If I Have Kidney Disease Can I Get A Catheterization? |02/06/2008 |
|Interview | |
|February 6, 2008 | |
| | |
| | |
|ABC News | |
| | |
|The Evidence Gap: Weighing the Costs of a CT Scan’s Look Inside the Heart |06/2008 |
|By ALEX BERENSON and REED ABELSON | |
|Published: June 29, 2008 | |
| | |
| | |
|New York Times | |
|New York, New York | |
| | |
|Debate: CT Controversy |07/2008 |
|Broadcast: Midmorning, 07/09/2008, 9:06 a.m. | |
| | |
| | |
|Minnesota Public Radio | |
|Rochester, Minnesota | |
| | |
|Quotes: FDA Delays Decision on Lilly Heart Drug |09/2008 |
|By RON WINSLOW SEPTEMBER 27, 2008 | |
| | |
| | |
|Wall Street Journal | |
|Washington, District of Columbia | |
| | |
|Interview: Medical News: PCI Study Suggests Optimal Wait Times for Surgery After Stenting |09/26/2008 |
|Interview | |
|By Peggy Peck, Executive Editor, MedPage Today | |
|Published: September 26, 2008 | |
|Reviewed by Zalman S. Agus, MD; Emeritus Professor | |
|University of Pennsylvania School of Medicine | |
| | |
| | |
|MedPage Today | |
|Pennsylvania | |
| | |
|Coronary Stent Study from Charanjit Rihal, MD |10/2008 |
|Video MD. | |
| | |
|Interviewed by Norman Swan. |05/11/2009 |
|Australian Broadcasting Corporation. | |
| | |
|Rochester, Minnesota | |
| | |
|Mayo Tests Replacing A Valve In A Beating Heart |06/01/2009 |
| | |
|Rochester, Minnesota | |
| | |
|Immediate Intervention for Heart Patients Similar to Waiting |09/01/2009 |
|Phone Interview with Nicole Ostrow, New York Reporter for Bloomberg News. Article posted | |
|September 1, 2009. | |
| | |
|Quotes in article: "The ever-evolving heart valve: |11/2009 |
|A life-saving side market for the next generation of high-profile transcatheter devices also | |
|promises growth for med-tech companies." | |
|Twin Cities Pioneer Press; in press and posted online | |
| | |
|Quotes in article: Certain Reflux Drugs Tied to Higher Post-Angioplasty Death Rate |11/16/2009 |
|US News, posted online | |
| |
|-post.html | |
| | |
|Addressed board from clinical perspective regarding the clopidogrel-PPI topic |11/19/2009 |
|Drug Safety Oversight Board Meeting, November 19, 2009 | |
| | |
|Interviewed by Drew Levinson regarding a recent lancet study about Ticagrelor. |01/13/2010 |
|CBS News 12 at Ten, Mankato, Minnesota. | |
| | |
|Radiation and Angioplasty Study |03/12/2010 |
|Mayo Clinic News Online. | |
| | |
| | |
|Mayo Clinic Study on Radiation Risks of Angioplasty |03/15/2010 |
|YouTube video presentation. | |
BIBLIOGRAPHY
Peer-reviewed Articles
1. Rihal CS, Gersh BJ, Whisnant JP, Rooke TW, Sundt TM Jr, O'Fallon WM, Ballard DJ. The association of coronary heart disease and survival following carotid endarterectomy: a population-based study in Olmsted County, Minnesota, 1970-1988. 63rd Scientific Session of the American Heart Association Dallas Texas, -15 1990 Nov 12; 0:0.
2. Gersh BJ, Rihal CS, Rooke TW, Ballard DJ. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol. 1991 Jul; 18(1):203-14. PMID:2050923.
3. Rihal CS, Nishimura RA, Holmes DR Jr. Percutaneous balloon mitral valvuloplasty: the learning curve. Am Heart J. 1991 Dec; 122(6):1750-6. PMID:1957768.
4. Rihal CS, Gersh BJ, Whisnant JP, Rooke TW, Sundt TM Jr, O'Fallon WM, Ballard DJ. Influence of coronary heart disease on morbidity and mortality after carotid endarterectomy: a population-based study in Olmsted County, Minnesota (1970-1988). J Am Coll Cardiol. 1992 May; 19(6):1254-60. PMID:1564225.
5. Rihal CS, Schaff HV, Frye RL, Bailey KR, Hammes LN, Holmes DR Jr. Long-term follow-up of patients undergoing closed transventricular mitral commissurotomy: a useful surrogate for percutaneous balloon mitral valvuloplasty? J Am Coll Cardiol. 1992 Oct; 20(4):781-6. PMID:1527287.
6. Rihal CS, Nishimura RA, Reeder GS, Holmes DR Jr. Percutaneous balloon mitral valvuloplasty: comparison of double and single (Inoue) balloon techniques. Cathet Cardiovasc Diagn. 1993 Jul; 29(3):183-90. PMID:8402840.
7. Chan RC, Rihal CS, Menke KK, Winter SJ, Holmes DR Jr. Adaptor device for shortening guide catheters to access distal lesions in coronary angioplasty. Cathet Cardiovasc Diagn. 1993 Nov; 30(3):249-51. PMID:8269499.
8. Klarich K, Rihal CS, Higano ST, Nishimura RA. Doppler echocardiographic examination following percutaneous balloon mitral valvuloplasty: a comparison of pressure half-time and continuity equation methods. American Society of Echocardiography. 1994.
9. Rihal CS, Holmes DR Jr. Percutaneous balloon mitral valvuloplasty: issues involved in comparing techniques. Catheterization & Cardiovascular Diagnosis. 1994(Suppl 2):35-41. PMCID:7994740.
10. Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh BJ. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators. J Am Coll Cardiol. 1994 Apr; 23(5):1091-5. PMID:8144774.
11. Nishimura RA, Rihal CS, Tajik AJ, Holmes DR Jr. Accurate measurement of the transmitral gradient in patients with mitral stenosis: a simultaneous catheterization and Doppler echocardiographic study. J Am Coll Cardiol. 1994 Jul; 24(1):152-8. PMID:8006259.
12. Rihal CS, Nishimura RA, Rumberger JA, Tajik AJ. Quantitative echocardiography: a comparison with ultrafast computed tomography in patients with chronic aortic regurgitation. J Heart Valve Dis. 1994 Jul; 3(4):417-24. PMID:7952317.
13. Farkouh ME, Rihal CS, Gersh BJ, Rooke TW, Hallett JW, O'Fallon WM, Ballard DJ. Influence of coronary heart disease on morbidity and mortality after lower extremity revascularization surgery: a population-based study in Olmsted County, Minnesota (1970-1987). J Am Coll Cardiol. 1994 Nov 1; 24(5):1290-6. PMID:7930252.
14. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation. 1994 Dec; 90(6):2772-9. PMID:7994820.
15. Rihal CS, Eagle KA, Mickel MC, Foster ED, Sopko G, Gersh BJ. Surgical therapy for coronary artery disease among patients with combined coronary artery and peripheral vascular disease. Circulation. 1995 Jan 1; 91(1):46-53. PMID:7805218.
16. Rihal CS, Davis KB, Kennedy JW, Gersh BJ. The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. Am J Cardiol. 1995 Feb 1; 75(4):220-3. PMID:7832126.
17. Grover A, Rihal CS. The importance of early patency after acute myocardial infarction. Curr Opin Cardiol. 1995 Jul; 10(4):361-6. PMID:7549077.
18. Rihal CS, Flather M, Hirsh J, Yusuf S. Advances in antithrombotic drug therapy for coronary artery disease. Eur Heart J. 1995 Jul; 16 Suppl D:10-21. PMID:8542866.
19. Kay MJ, Kahana LM, Rihal CS. Diffuse smooth muscle proliferation of the lungs with severe pulmonary hypertension. Hum Pathol. 1996; 27(9):969-74. PMID:8816894.
20. Rihal CS, Yusuf S. Chronic coronary artery disease: drugs, angioplasty, or surgery? Tailor the treatment to the patient. BMJ. 1996; 312:265-6. PMID:8611770. PMCID:2349862.
21. Jolly KS, Pais P, Rihal CS. Coronary artery disease among South Asians: identification of a high risk population. Can J Cardiol. 1996 Jun; 12(6):569-71. PMID:8665418.
22. Klarich KW, Rihal CS, Nishimura RA. Variability between methods of calculating mitral valve area: simultaneous Doppler echocardiographic and cardiac catheterization studies conducted before and after percutaneous mitral valvuloplasty. J Am Soc Echocardiogr. 1996 Sep-Oct; 9(5):684-90. PMID:8887872.
23. Grover A, Rihal CS. Combined coronary and peripheral vascular disease: efficient evaluation and effective management. Contemporary Internal Medicine. 1997; 9(9):36-44.
24. Hasdai D, Berger PB, Bell MR, Rihal CS, Garratt KN, Holmes DR Jr. The changing face of coronary interventional practice. The Mayo Clinic experience. Arch Intern Med. 1997 Mar 24; 157(6):677-82. PMID:9080922.
25. Rihal CS. Five-year survival rates following PTCA and CABG were not significantly different. Evid Based Cardiovasc Med. 1997 Apr; 1(1):23. PMID:16379693.
26. Hasdai D, Bell MR, Grill DE, Berger PB, Garratt KN, Rihal CS, Hammes LN, Holmes DR Jr. Outcome > or = 10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol. 1997 Apr 15; 79(8):1005-11. PMID:9114755.
27. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation. 1997 Sep 16; 96(6):1882-7. PMID:9323076.
28. Hasdai D, Rihal CS, Lerman A, Grill DE, Holmes DR Jr. Smokers undergoing percutaneous coronary revascularization present with fewer narrowings in the target coronary artery. Am J Cardiol. 1997 Nov 1; 80(9):1212-4. PMID:9359553.
29. Rihal CS. Probucol reduced the rates of restenosis following scheduled PTCA. Evid Based Cardiovasc Med. 1997 Dec; 1(4):108. PMID:16379763.
30. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Influence of Coronary Artery Disease on Noncardiac Surgery Risk. Cardiology Reviews. 1998; 15:24-6.
31. Rihal CS. Direct angioplasty versus medical thrombolysis for acute myocardial infarction. Mayo Clinic, Department of Internal Medicine Intramural Newsletter (Cardiovascular Diseases). 1998; 20(8):3-5.
32. Sutton-Tyrrell K, Rihal C, Sellers MA, Burek K, Trudel J, Roubin G, Brooks MM, Grogan M, Sopko G, Keller N, Jandova R, for the Bari Investigators. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1998 Feb 15; 81(4):375-81. PMID:9485122.
33. Rihal CS. The role of myocardial revascularization preceding noncardiac surgery. Prog Cardiovasc Dis. 1998 Mar-Apr; 40(5):383-404. PMID:9585373.
34. Mathew V, Rihal CS, Berger PB, Bell MR, Garratt KN, Holmes R Jr. Clinical outcome of patients undergoing multivessel coronary stent implantation. Int J Cardiol. 1998 Mar 13; 64(1):1-7. PMID:9579810.
35. Rihal CS, Garratt KN, Holmes DR Jr. Rotational atherectomy for bifurcation lesions of the coronary circulation: technique and initial experience. Int J Cardiol. 1998 Jun 1; 65(1):1-9. PMID:9699924.
36. Hasdai D, Rihal CS, Bell MR, Berger PB, Grill DE, Garratt KN, Holmes DR Jr. Abciximab administration and outcome after intracoronary stent implantation. Am J Cardiol. 1998 Sep 15; 82(6):705-9. PMID:9761077.
37. Hasdai D, Lerman A, Grill DE, Rihal CS, Holmes DR Jr. Medical therapy after successful percutaneous coronary revascularization. Ann Intern Med. 1999 Jan 19; 130(2):108-15. PMID:10068356.
38. Hasdai D, Lerman A, Rihal CS, Criger DA, Garratt KN, Betriu A, White HD, Topol EJ, Granger CB, Ellis SG, Califf RM, Holmes DR Jr. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J. 1999 Apr; 137(4 Pt 1):612-20. PMID:10097222.
39. Wilson SH, Rihal CS, Bell MR, Velianou JL, Holmes DR Jr, Berger PB. Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin. Am J Cardiol. 1999 Apr 1; 83(7):1006-11. PMID:10190510.
40. Rihal CS, Sutton-Tyrrell K, Guo P, Keller NM, Jandova R, Sellers MA, Schaff HV, Holmes DR Jr. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. Circulation. 1999 Jul 13; 100(2):171-7. PMID:10402447.
41. Ellis SG, Effron MB, Gold HK, Leon MB, Popma JJ, Serruys PWJC, Colombo A, Cohen N, Juran N, Werner W, Heuser RR, Spooner S, Rihal CS, Fox R, Brennan J, Ricci D, Teirstein PS, Norman S, Morris N, Zidar J, Rund M. Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). Circulation. 1999 Aug 24; 100(8):799-806. PMID:10458714.
42. Burek KA, Sutton-Tyrrell K, Brooks MM, Naydeck B, Keller N, Sellers MA, Roubin G, Jandova R, Rihal CS. Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 1999 Sep; 34(3):716-21. PMID:10483952.
43. Ommen SR, Nishimura RA, Grill DE, Holmes DR Jr, Rihal CS. Comparison of long-term results of percutaneous mitral balloon valvotomy with closed transventricular mitral commissurotomy at a single North American Institution. Am J Cardiol. 1999 Sep 1; 84(5):575-7. PMID:10482158.
44. Al Suwaidi J, Higano ST, Holmes DR Jr, Rihal CS, Lerman A. Measuring maximal percent area stenosis poststent placement with intracoronary Doppler and the continuity equation and correlation with intracoronary ultrasound and angiography. Am J Cardiol. 1999 Sep 15; 84(6):650-4. PMID:10498133.
45. Berger PB, Bell MR, Rihal CS, Ting H, Barsness G, Garratt K, Bellot V, Mathew V, Melby S, Hammes L, Grill D, Holmes DR Jr. Clopidogrel versus ticlopidine after intracoronary stent placement. J Am Coll Cardiol. 1999 Dec; 34(7):1891-4. PMID:10588199.
46. Singh M, Mathew V, Garratt KN, Berger PB, Grill DE, Bell MR, Rihal CS, Holmes DR Jr. Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic. Am J Med. 2000 Feb 15; 108(3):187-92. PMID:10723971.
47. Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH, Bresnahan JF, Grill DE, Holmes DR Jr. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol. 2000 Mar 15; 35(4):929-36. PMID:10732890.
48. Wilson SH, Berger PB, Mathew V, Bell MR, Garratt KN, Rihal CS, Bresnahan JF, Grill DE, Melby S, Holmes DR Jr. Immediate and late outcomes after direct stent implantation without balloon predilation. J Am Coll Cardiol. 2000 Mar 15; 35(4):937-43. PMID:10732891.
49. Rihal CS, Grill DE, Bell MR, Berger PB, Garratt KN, Holmes DR Jr. Prediction of death after percutaneous coronary interventional procedures. Am Heart J. 2000 Jun; 139(6):1032-8. PMID:10827384. DOI:10.1067/mhj.2000.105299.
50. Holmes DR Jr, Berger PB, Garratt KN, Mathew V, Bell MR, Barsness GW, Higano ST, Grill DE, Hammes LN, Rihal CS. Application of the New York State PTCA mortality model in patients undergoing stent implantation. Circulation. 2000 Aug 1; 102(5):517-22. PMID:10920063.
51. Singh M, Rihal CS, Berger PB, Bell MR, Grill DE, Garratt KN, Barseness GW, Holmes DR Jr. Improving outcome over time of percutaneous coronary interventions in unstable angina. J Am Coll Cardiol. 2000 Sep; 36(3):674-8. PMID:10987583.
52. Suwaidi JA, Garratt KN, Berger PB, Rihal CS, Bell MR, Grill DE, Holmes DR Jr. Immediate and one-year outcome of intracoronary stent implantation in small coronary arteries with 2.5-mm stents. Am Heart J. 2000 Dec; 140(6):898-905. PMID:11099994.
53. Gersh BJ, Rihal CS. Coronary revascularization in patients with chronic stable angina: implications of the randomized trials. ACC Current Journal Review. 2001 Jan-Feb; 10(1):76-81. DOI:10.1016/S1062-1458(00)00201-4.
54. Ting HH, Tahirkheli NK, Berger PB, McCarthy JT, Timimi FK, Mathew V, Rihal CS, Hasdai D, Holmes DR Jr. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure. Am J Cardiol. 2001 Mar 1; 87(5):630-3, A9. PMID:11230851.
55. Wilson SH, Bell MR, Rihal CS, Bailey KR, Holmes DR Jr, Berger PB. Infarct artery reocclusion after primary angioplasty, stent placement, and thrombolytic therapy for acute myocardial infarction. Am Heart J. 2001 May; 141(5):704-10. PMID:11320356. DOI:10.1067/mhj.2001.114971.
56. Berger PB, Bellot V, Bell MR, Horlocker TT, Rihal CS, Hallett JW, Dalzell C, Melby SJ, Charnoff NE, Holmes DR Jr. An immediate invasive strategy for the treatment of acute myocardial infarction early after noncardiac surgery. Am J Cardiol. 2001 May 1; 87(9):1100-2, A6, A9. PMID:11348610.
57. Kalra S, Bell MR, Rihal CS. Alveolar hemorrhage as a complication of treatment with abciximab. Chest. 2001 Jul; 120(1):126-31. PMID:11451827.
58. Powell BD, Holmes DR Jr, Nishimura RA, Rihal CS. Calcium embolism of the coronary arteries after percutaneous mitral balloon valvuloplasty. Mayo Clin Proc. 2001 Jul; 76(7):753-7. PMID:11444410.
59. Di Segni E, Higano ST, Rihal CS, Holmes DR Jr, Lennon R, Lerman A. Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Catheter Cardiovasc Interv. 2001 Sep; 54(1):34-40. PMID:11553945.
60. Mathew V, Farkouh ME, Gersh BJ, Rihal CS, Reeder GS, Grill DE, Urban LH, Kopecky SL, Chesebro JH, Holmes DR Jr. Early coronary angiography improves long-term survival in unstable angina. Am Heart J. 2001 Nov; 142(5):768-74. PMID:11685161. DOI:10.1067/mhj.2001.119126.
61. Orford JL, Fasseas P, Denktas AE, Bybee KA, Rihal CS, Holmes DR. Refractory angina and anterior ischemia in a patient with a patent left internal mammary artery bypass graft. J Invasive Cardiol. 2001 Nov; 13(11):763-6. PMID:11689723.
62. Pettersen MD, Ammash NM, Hagler DJ, Rihal CS, Cabalka AK. Endovascular stent implantation in a coronary artery to pulmonary artery fistula in a patient with pulmonary atresia with ventricular septal defect and severe cyanosis. Catheter Cardiovasc Interv. 2001 Nov; 54(3):358-62. PMID:11747165.
63. Singh M, Berger PB, Ting HH, Rihal CS, Wilson SH, Lennon RJ, Reeder GS, Bresnahan JF, Holmes DR Jr. Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience). Am J Cardiol. 2001 Nov 15; 88(10):1091-6. PMID:11703950.
64. Suh WW, Grill DE, Rihal CS, Bell MR, Holmes DR, Garratt KN. Unrestricted availability of intracoronary stents is associated with decreased abrupt vascular closure rates and improved early clinical outcomes. Catheter Cardiovasc Interv. 2002 Mar; 55(3):294-302. PMID:11870931.
65. Bruce CJ, Nishimura RA, Rihal CS, Hagler DJ, Higano ST, Seward JB, Holmes DR. Intracardiac echocardiography in the interventional catheterization laboratory: Preliminary experience with a novel, phased-array transducer. Am J Cardiol. 2002 Mar 1; 89(5):635-40. PMID:11867061.
66. Rihal CS, Textor SC, Breen JF, McKusick MA, Grill DE, Hallett JW, Holmes DR. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002 Apr; 77(4):309-16. PMID:11936924.
67. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002 Apr 3; 39(7):1113-9. PMID:11923033.
68. Singh M, Tiede DJ, Mathew V, Garratt KN, Lennon RJ, Holmes DR Jr, Rihal CS. Rheolytic thrombectomy with Angiojet in thrombus-containing lesions. Catheter Cardiovasc Interv. 2002 May; 56(1):1-7. PMID:11979522. DOI:10.1002/ccd.10176.
69. Brilakis ES, Mavrogiorgos NC, Kopecky SL, Rihal CC, Gersh BJ, Williams BA, Clements IP. Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction. Am J Cardiol. 2002 May 1; 89(9):1013-8. PMID:11988187.
70. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002 May 14; 105(19):2259-64. PMID:12010907.
71. Singh M, Lennon RJ, Holmes DR Jr, Bell MR, Rihal CS. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol. 2002 Aug 7; 40(3):387-93. PMID:12142101.
72. Orford JL, Lennon R, Melby S, Fasseas P, Bell MR, Rihal CS, Holmes DR, Berger PB. Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. J Am Coll Cardiol. 2002 Nov 6; 40(9):1567-72. PMID:12427407.
73. Sudlow C, Lonn E, Pignone M, Ness A, Rihal CS. Secondary Prevention of Ischemic Cardiac Events. Clinical Evidence. 2003; 9:166-205.
74. Powell BD, Lennon RJ, Lerman A, Bell MR, Berger PB, Higano ST, Holmes DR Jr, Rihal CS. Association of body mass index with outcome after percutaneous coronary intervention. Am J Cardiol. 2003 Feb 15; 91(4):472-6. PMID:12586271.
75. Singh M, Khandheria BK, Gura GM, Rihal CS. Telemedicine links between developing and developed nations. Indian Heart J. 2003 Mar-Apr; 55(2):188-92. PMID:12921340.
76. Best PJ, Lennon R, Gersh BJ, Ting HH, Rihal CS, Bell MR, Herzog CA, Holmes DR Jr, Berger PB. Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions. Am Heart J. 2003 Aug; 146(2):345-50. PMID:12891206. DOI:10.1016/S0002-8703(03)00231-X.
77. Brilakis ES, Wright RS, Kopecky SL, Mavrogiorgos NC, Reeder GS, Rihal CS, Gersh BJ, Williams BA, Clements IP. Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. Am Heart J. 2003 Nov; 146(5):811-8. PMID:14597929.
78. Rihal CS, Raco DL, Gersh BJ, Yusuf S. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation. 2003 Nov 18; 108(20):2439-45. PMID:14623791. DOI:10.1161/01.CIR.0000094405.21583.7C.
79. Singh M, Rihal CS, Selzer F, Kip KE, Detre K, Holmes DR. Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol. 2003 Nov 19; 42(10):1722-8. PMID:14642678.
80. Pignone M, Rihal C, Bazian Ltd. Secondary prevention of ischemic cardiac events. Elin Evid. 2003 Dec(10):188-230.
81. Singh M, Rihal CS. Validation of Mayo Clinic risk adjustment model for in-hospital complications following percutaneous coronary interventions using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol. 2004 Mar; 13(3):56. DOI:10.1016/j.accreview.2004.02.054.
82. Powell BD, Rihal CS, Bell MR, Zehr KJ, Holmes DR. Anticipated impact of drug-eluting Stents on referral patterns for coronary artery bypass graft surgery: A population-based angiographic analysis. Mayo Clin Proc. 2004 Jun; 79(6):769-72. PMID:15182091.
83. Prasad A, Lennon RJ, Rihal CS, Berger PB, Holmes DR Jr. Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization. Am Heart J. 2004 Jun; 147(6):1066-70. PMID:15199357. DOI:10.1016/j.ahj.2003.07.030.
84. Singh M, Rihal CS, Lennon RJ, Garratt KN, Holmes DR. Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions. J Am Coll Cardiol. 2004 Jul 21; 44(2):357-61. PMID:15261931.
85. Patel JB, Borgeson DD, Barnes ME, Rihal CS, Daly RC, Redfield MM. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail. 2004 Aug; 10(4):285-91. PMID:15309693.
86. Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG, Wright RS, Rihal CS. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004 Aug 1; 94(3):343-6. PMID:15276100.
87. Singh M, Lennon RJ, Darbar D, Gersh BJ, Holmes DR Jr, Rihal CS. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. Mayo Clin Proc. 2004 Sep; 79(9):1113-8. PMID:15357032.
88. Mathew V, Lennon RJ, Rihal CS, Bresnahan JF, Holmes DR Jr. Applicability of distal protection for aortocoronary vein graft interventions in clinical practice. Catheter Cardiovasc Interv. 2004 Oct; 63(2):148-51. PMID:15390255. DOI:10.1002/ccd.20102.
89. Maniu CV, Patel JB, Reuter DG, Meyer DM, Edwards WD, Rihal CS, Redfield MM. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol. 2004 Oct 19; 44(8):1652-61. PMID:15489099.
90. Herrmann J, Higano ST, Lenon RJ, Rihal CS, Lerman A. Myocardial bridging is associated with alteration in coronary vasoreactivity. Eur Heart J. 2004 Dec; 25(23):2134-42. PMID:15571829.
91. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, Rihal CS. Systematic review: Transient left ventricular apical ballooning: A syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004 Dec 7; 141(11):858-65. PMID:15583228.
92. Chen LY, Lennon RJ, Grantham JA, Berger PB, Mathew V, Singh M, Holmes DR Jr, Rihal CS. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. Am J Cardiol. 2005 Feb 1; 95(3):349-54. PMID:15670543. DOI:10.1016/j.amjcard.2004.09.032.
93. Skelding KA, Rihal CS. Contemporary percutaneous reperfusion therapy for acute myocardial infarction in the elderly. J Geriatr Cardiol. 2005 Mar; 2(1):48-53.
94. Singh M, Rihal CS, Lennon RJ, Garratt KN, Holmes DR Jr. A critical appraisal of current models of risk stratification for percutaneous coronary interventions. Am Heart J. 2005 May; 149(5):753-60. PMID:15894953. DOI:10.1016/j.ahj.2005.01.028.
95. Alegria JR, Herrmann J, Holmes DR Jr, Lerman A, Rihal CS. Myocardial bridging. Eur Heart J. 2005 Jun; 26(12):1159-68. Epub 2005 Mar 11. PMID:15764618. DOI:10.1093/eurheartj/ehi203.
96. Burkle CM, Nuttall GA, Rihal CS. Cardiopulmonary bypass support for percutaneous coronary interventions: what the anesthesiologist needs to know. J Cardiothorac Vasc Anesth. 2005 Aug; 19(4):501-4. PMID:16085258. DOI:10.1053/j.jvca.2004.10.003.
97. Chaowalit N, Somers VK, Pellikka PA, Rihal CS, Lopez-Jimenez F. Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis. 2005 Sep 22.
98. Singh M, Rihal CS, Lennon RJ, Garratt KN, Mathew V, Holmes DR Jr. Prediction of complications following nonemergency percutaneous coronary interventions. Am J Cardiol. 2005 Oct 1; 96(7):907-12. PMID:16188514. DOI:10.1016/j.amjcard.2005.05.045.
99. Jaber WA, Lennon RJ, Mathew V, Holmes DR Jr, Lerman A, Rihal CS. Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator. J Am Coll Cardiol. 2005 Oct 18; 46(8):1473-8. Epub 2005 Sep 23. PMID:16226170. DOI:10.1016/j.jacc.2005.06.070.
100. Brilakis ES, Best PJM, Elesber AA, Barsness GW, Lennon RJ, Holmes DR, Rihal CS, Garratt KN. Incidence, retrieval methods, and outcomes of stent loss during percutaneous coronary intervention: A large single-center experience. Catheter Cardiovasc Interv. 2005 Nov; 66(3):333-40. PMID:16142808.
101. Yang EH, Gumina RJ, Lennon RJ, Holmes DR Jr, Rihal CS, Singh M. Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003. J Am Coll Cardiol. 2005 Dec 6; 46(11):2004-9. Epub 2005 Nov 04. PMID:16325032. DOI:10.1016/j.jacc.2005.06.083.
102. Sprung J, Ritter MJ, Rihal CS, Warner ME, Wilson GA, Williams BA, Stevens SR, Schroeder DR, Bourke DL, Warner DO. Outcomes of cardiopulmonary resuscitation and predictors of survival in patients undergoing coronary angiography including percutaneous coronary interventions. Anesth Analg. 2006 Jan; 102(1):217-24. PMID:16368833. DOI:10.1213/01.ane.0000189082.54614.26.
103. Yang EH, McConnell JP, Lennon RJ, Barsness GW, Pumper G, Hartman SJ, Rihal CS, Lerman LO, Lerman A. Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2006 Jan; 26(1):106-11. Epub 2005 Oct 20. PMID:16239595. DOI:10.1161/01.ATV.0000191655.87296.ab.
104. Bybee KA, Murphy J, Prasad A, Wright RS, Lerman A, Rihal CS, Chareonthaitawee P. Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome. J Nucl Cardiol. 2006 Mar-Apr; 13(2):244-50. PMID:16580961. DOI:10.1016/j.nuclcard.2006.01.016.
105. Liang HY, Cauduro SA, Pellikka PA, Bailey KR, Grossardt BR, Yang EH, Rihal C, Seward JB, Miller FA, Abraham TP. Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events. Am J Cardiol. 2006 Mar 15; 97(6):866-71. Epub 2006 Jan 30. PMID:16516591. DOI:10.1016/j.amjcard.2005.09.136.
106. Elesber AA, Best PJ, Lennon RJ, Mathew V, Rihal CS, Lerman LO, Lerman A. Plasma 8-iso-prostaglandin F2alpha, a marker of oxidative stress, is increased in patients with acute myocardial infarction. Free Radic Res. 2006 Apr; 40(4):385-91. PMID:16517503. DOI:10.1080/10715760500539154.
107. Ting HH, Raveendran G, Lennon RJ, Long KH, Singh M, Wood DL, Gersh BJ, Rihal CS, Holmes DR Jr. A total of 1,007 percutaneous coronary interventions without onsite cardiac surgery: acute and long-term outcomes. J Am Coll Cardiol. 2006 Apr 18; 47(8):1713-21. Epub 2006 Mar 13. PMID:16631012. DOI:10.1016/j.jacc.2006.02.039.
108. Long KH, McMurtry EK, Lennon RJ, Chapman AC, Singh M, Rihal CS, Wood DL, Holmes DR Jr, Ting HH. Elective percutaneous coronary intervention without on-site cardiac surgery: clinical and economic implications. Med Care. 2006 May; 44(5):406-13. PMID:16641658. DOI:10.1097/01.mlr.0000207489..
109. Anakwenze OA, Lerman A, Edwards WD, Gertz MA, Rihal CS. Death during coronary angiography in a woman with cardiac amyloidosis. Amyloid. 2006 Jun; 13(2):108-10. PMID:16911965. DOI:10.1080/13506120600722712.
110. Chaowalit N, Somers VK, Pellikka PA, Rihal CS, Lopez-Jimenez F. Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis. 2006 Jun; 186(2):354-9. Epub 2005 Sep 23. PMID:16183065. DOI:10.1016/j.atherosclerosis.2005.08.004.
111. Holmes DR Jr, Rihal C. The 5-year projection on the future of interventional cardiology. Am Heart Hosp J. 2006 Summer; 4(3):195-201. PMID:16894256.
112. Powell BD, Redfield MM, Bybee KA, Freeman WK, Rihal CS. Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol. 2006 Jul 1; 98(1):116-20. Epub 2006 May 06. PMID:16784933. DOI:10.1016/j.amjcard.2006.01.063.
113. Bae JH, Lerman A, Yang E, Rihal C. Feasibility of a pressure wire and single arterial puncture for assessing aortic valve area in patients with aortic stenosis. J Invasive Cardiol. 2006 Aug; 18(8):359-62. PMID:16877782.
114. Bae JH, Rihal CS, Lerman A. Tissue characterization of coronary plaques using intravascular ultrasound/virtual histology. Korean Circ. J. 2006 Aug; 36(8):553-8.
115. Rihal CS, Kamath CC, Holmes DR Jr, Reller MK, Anderson SS, McMurtry EK, Long KH. Economic and clinical outcomes of a physician-led continuous quality improvement intervention in the delivery of percutaneous coronary intervention. Am J Manag Care. 2006 Aug; 12(8):445-52. PMID:16886887.
116. Singh M, Lennon RJ, Roger VL, Rihal CS, Halligan S, Lerman A, Yang E, Holmes DR Jr. Relation of preprocedural statin therapy to in-hospital procedural complications following percutaneous coronary interventions in patients with hyperlipidemia. Am J Cardiol. 2006 Aug 1; 98(3):325-30. Epub 2006 Jun 12. PMID:16860017. DOI:10.1016/j.amjcard.2006.02.036.
117. Elesber A, Lerman A, Bybee KA, Murphy JG, Barsness G, Singh M, Rihal CS, Prasad A. Myocardial perfusion in apical ballooning syndrome correlate of myocardial injury. Am Heart J. 2006 Sep; 152(3):469.e9-13. PMID:16923415. DOI:10.1016/j.ahj.2006.06.007.
118. Bae JH, Kim WS, Rihal CS, Lerman A. Individual measurement and significance of carotid intima, media, and intima-media thickness by B-mode ultrasonographic image processing. Arterioscler Thromb Vasc Biol. 2006 Oct; 26(10):2380-5. Epub 2006 Aug 10. PMID:16902160. DOI:10.1161/01.ATV.0000240420.36229.f9.
119. Ting HH, Yang EH, Rihal CS. Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction. Ann Intern Med. 2006 Oct 17; 145(8):610-7. PMID:17043342.
120. Bae JH, Rihal CS, Edwards BS, Kushwaha SS, Mathew V, Prasad A, Holmes DR Jr, Lerman A. Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. Transplantation. 2006 Oct 27; 82(8):1108-11. PMID:17060862. DOI:10.1097/01.tp.0000230378.61437.a5.
121. Rihal CS, Gersh BJ. Is incomplete revascularization during PCI and stenting associated with adverse long-term outcomes? Nat Clin Pract Cardiovasc Med. 2006 Nov; 3(11):588-9. PMID:17063160. DOI:10.1038/ncpcardio0685.
122. Prasad A, Singh M, Lerman A, Lennon RJ, Holmes DR Jr, Rihal CS. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol. 2006 Nov 7; 48(9):1765-70. Epub 2006 Oct 17. PMID:17084247. DOI:10.1016/j.jacc.2006.04.102.
123. Doyle BJ, Konz BA, Lennon RJ, Bresnahan JF, Rihal CS, Ting HH. Ambulation 1 hour after diagnostic cardiac catheterization: a prospective study of 1009 procedures. Mayo Clin Proc. 2006 Dec; 81(12):1537-40. PMID:17165631.
124. Gumina RJ, Murphy JG, Rihal CS, Lennon RJ, Wright RS. Long-term survival after right ventricular infarction. Am J Cardiol. 2006 Dec 15; 98(12):1571-3. Epub 2006 Oct 18. PMID:17145212. DOI:10.1016/j.amjcard.2006.07.033.
125. Liang HY, Cauduro S, Pellikka P, Wang J, Urheim S, Yang EH, Rihal C, Belohlavek M, Khandheria B, Miller FA, Abraham TP. Usefulness of two-dimensional speckle strain for evaluation of left ventricular diastolic deformation in patients with coronary artery disease. Am J Cardiol. 2006 Dec 15; 98(12):1581-6. Epub 2006 Oct 25. PMID:17145214. DOI:10.1016/j.amjcard.2006.07.038.
126. Bae JH, Rihal CS, Hyun DW, Park KR, Kwon TG, Yoon HJ, Lerman A. Hypertension, a low ejection fraction and severe angiographic findings are associated with smooth muscle dysfunction in patients with coronary atherosclerosis. Korean Circ. J. 2007; 37(10):470-4.
127. Bybee KA, Motiei A, Syed IS, Kara T, Prasad A, Lennon RJ, Murphy JG, Hammill SC, Rihal CS, Wright RS. Electrocardiography cannot reliably differentiate transient left ventricular apical ballooning syndrome from anterior ST-segment elevation myocardial infarction. J Electrocardiol. 2007 Jan; 40(1):38.e1-6. Epub 2006 Oct 25. PMID:17067626. DOI:10.1016/j.jelectrocard.2006.04.007.
128. Friedman PA, Munger TM, Torres N, Rihal C. Percutaneous endocardial and epicardial ablation of hypotensive ventricular tachycardia with percutaneous left ventricular assist in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 2007 Jan; 18(1):106-9. PMID:17229307.
129. Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Jan 23; 49(3):350-7. PMID:17239717.
130. Raveendran G, Ting HH, Best PJ, Holmes DR Jr, Lennon RJ, Singh M, Bell MR, Long KH, Rihal CS. Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction. Mayo Clin Proc. 2007 Feb; 82(2):196-202. PMID:17290727.
131. Doyle BJ, Godfrey MJ, Lennon RJ, Ryan JL, Bresnahan JF, Rihal CS, Ting HH. Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization. Catheter Cardiovasc Interv. 2007 Feb 1; 69(2):203-8. PMID:17195965. DOI:10.1002/ccd.20937.
132. Sandhu G, Doyle B, Singh R, Bell M, Bresnahan J, Mathew V, Holmes D, Lerman A, Rihal C. Frequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-up. Am J Cardiol. 2007 Feb 15; 99(4):465-9. Epub 2006 Dec 21. PMID:17293185. DOI:10.1016/j.amjcard.2006.08.058.
133. Bae JH, Hyun DW, Kwon TG, Yoon HY, Lerman A, Rihal CS. Serum uric acid is associated with cardiovascular events in patients with coronary artery disease. Korean Circ J. 2007 Apr; 37(4):161-6 Epub 2007 Apr 30. DOI:10.4070/kcj.2007.37.4.161.
134. Jacobson KM, Hall Long K, McMurtry EK, Naessens JM, Rihal CS. The economic burden of complications during percutaneous coronary intervention. Qual Saf Health Care. 2007 Apr; 16(2):154-9. PMID:17403766. PMCID:2653156. DOI:10.1136/qshc.2006.019331.
135. Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes DR Jr. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. J Am Coll Cardiol. 2007 Apr 17; 49(15):1611-8. Epub 2007 Apr 02. PMID:17433951. DOI:10.1016/j.jacc.2006.12.040.
136. Skelding KA, Best PJ, Bartholomew BA, Lennon RJ, O'Neill WW, Rihal CS. Validation of a predictive risk score for radiocontrast-induced nephropathy following percutaneous coronary intervention. J Invasive Cardiol. 2007 May; 19(5):229-33. PMID:17476039.
137. Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS, EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007 May 9; 297(18):2001-9. PMID:17488965.
138. Lavi S, Prasad A, Yang EH, Mathew V, Simari RD, Rihal CS, Lerman LO, Lerman A. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation. 2007 May 22; 115(20):2621-7. Epub 2007 May 07. PMID:17485580. DOI:10.1161/CIRCULATIONAHA.106.641654.
139. Lavi S, McConnell JP, Rihal CS, Prasad A, Mathew V, Lerman LO, Lerman A. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation. 2007 May 29; 115(21):2715-21. PMID:17502572.
140. Elesber AA, Redfield MM, Rihal CS, Prasad A, Lavi S, Lennon R, Mathew V, Lerman LO, Lerman A. Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans. Am Heart J. 2007 Jun; 153(6):1081-7. PMID:17540214.
141. Singh M, Rihal CS, Lennon RJ, Spertus J, Rumsfeld JS, Holmes DR Jr. Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores. Mayo Clin Proc. 2007 Jun; 82(6):701-8. PMID:17550750.
142. Singh M, Rihal CS, Gersh BJ, Lennon RJ, Prasad A, Sorajja P, Gullerud RE, Holmes DR Jr. Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience. Circulation. 2007 Jun 5; 115(22):2835-41. Epub 2007 May 28. PMID:17533185. DOI:10.1161/CIRCULATIONAHA.106.632679.
143. Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007 Jul 31; 50(5):448-52. Epub 2007 Jul 16. PMID:17662398. DOI:10.1016/j.jacc.2007.03.050.
144. Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ, Lim CC, Bresnahan JF, Jaffe AS, Holmes DR, Bell MR. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation. 2007 Aug 14; 116(7):729-36. Epub 2007 Aug 01. PMID:17673456. DOI:10.1161/CIRCULATIONAHA.107.699934.
145. Chaowalit N, Somers VK, Pellikka PA, Rihal CS, Lopez-Jimenez F. Adipose tissue of atrial septum as a marker of coronary artery disease. Chest. 2007 Sep; 132(3):817-22. Epub 2007 Jun 15. PMID:17573499. DOI:10.1378/chest.06-2425.
146. Gerber Y, Rihal CS, Sundt TM 3rd, Killian JM, Weston SA, Therneau TM, Roger VL. Coronary revascularization in the community. A population-based study, 1990 to 2004. J Am Coll Cardiol. 2007 Sep 25; 50(13):1223-9. Epub 2007 Sep 10. PMID:17888838. DOI:10.1016/j.jacc.2007.06.022.
147. Zhang L, Visscher D, Rihal C, Aubry MC. Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int. 2007 Oct; 27(12):1163-5. Epub 2007 May 23. PMID:17520258. DOI:10.1007/s00296-007-0362-1.
148. Lavi S, Rihal CS, Yang EH, Fassa AA, Elesber A, Lennon RJ, Mathew V, David HR Jr, Lerman A. The effect of drug eluting stents on cardiovascular events in patients with intermediate lesions and borderline fractional flow reserve. Catheter Cardiovasc Interv. 2007 Oct 1; 70(4):525-31. PMID:17896397. DOI:10.1002/ccd.21154.
149. Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol. 2007 Oct 2; 50(14):1310-4. Epub 2007 Sep 17. PMID:17903628. DOI:10.1016/j.jacc.2007.06.028.
150. Sorajja P, Cabalka AK, Hagler DJ, Reeder GS, Chandrasekaran K, Cetta F, Rihal CS. Successful percutaneous repair of perivalvular prosthetic regurgitation. Catheter Cardiovasc Interv. 2007 Nov 15; 70(6):815-23. PMID:18022905. DOI:10.1002/ccd.21270.
151. Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR Jr. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation. 2007 Nov 20; 116(21):2391-8. Epub 2007 Nov 05. PMID:17984377. DOI:10.1161/CIRCULATIONAHA.107.707331.
152. Raichlin E, Bae JH, Khalpey Z, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Rihal C, Lerman A, Kushwaha SS. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation. 2007 Dec 4; 116(23):2726-33. Epub 2007 Nov 19. PMID:18025531. DOI:10.1161/CIRCULATIONAHA.107.692996.
153. Dib C, Prasad A, Friedman PA, Ahmad E, Rihal CS, Hammill SC, Asirvatham SJ. Malignant arrhythmia in apical ballooning syndrome: risk factors and outcomes. Indian Pacing Electrophysiol J. 2008; 8(3):182-92. Epub 2008 Aug 01. PMID:18679529. PMCID:2490812.
154. Lavi S, Yang EH, Prasad A, Mathew V, Barsness GW, Rihal CS, Lerman LO, Lerman A. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension. 2008 Jan; 51(1):127-33. PMID:18086957. DOI:10.1161/HYPERTENSIONAHA.107.099986.
155. Rihal CS. What physicians should know about coronary stents. Minn Med. 2008 Jan; 91(1):44-6. PMID:18269069.
156. Holmes DR Jr, Bell MR, Gersh BJ, Rihal CS, Haro LH, Bjerke CM, Lennon RJ, Lim CC, Ting HH. Systems of care to improve timeliness of reperfusion therapy for ST-segment elevation myocardial infarction during off hours: the Mayo Clinic STEMI protocol. JACC Cardiovasc Interv. 2008 Feb; 1(1):88-96. PMID:19393151. DOI:10.1016/j.jcin.2007.10.002.
157. Lavi S, McConnell JP, Lavi R, Barsness GW, Rihal CS, Novak GD, Lerman LO, Lerman A. Association between the paraoxonase-1 192Q>R allelic variant and coronary endothelial dysfunction in patients with early coronary artery disease. Mayo Clin Proc. 2008 Feb; 83(2):158-64. PMID:18241625.
158. Elesber A, Nishimura RA, Rihal CS, Ommen SR, Schaff HV, Holmes DR Jr. Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2008 Feb 15; 101(4):516-20. Epub 2007 Dec 20. PMID:18312769. DOI:10.1016/j.amjcard.2007.09.111.
159. Menon SC, Rihal C, Cabalka AK. Abdominal aortic pseudoaneurysm repair using the Amplatzer septal occluder device. J Invasive Cardiol. 2008 Mar; 20(3):E77-8. PMID:18316837.
160. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008 Mar; 155(3):408-17. Epub 2008 Jan 31. PMID:18294473. DOI:10.1016/j.ahj.2007.11.008.
161. Bunch TJ, Rihal CS, Gumina RJ, Cooper L, Caplice NM. Progression of nonculprit plaque stenosis following successful percutaneous intervention. Angiology. 2008 Apr-May; 59(2):236-9. Epub 2008 Apr 02. PMID:18388075. DOI:10.1177/0003319707306446.
162. Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, Holmes DR, Rihal CS. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv. 2008 Apr; 1(2):202-9. PMID:19463301. DOI:10.1016/j.jcin.2007.12.006.
163. Vlaar PJ, Lennon RJ, Rihal CS, Singh M, Ting HH, Bresnahan JF, Holmes DR Jr. Drug-eluting stents in octogenarians: early and intermediate outcome. Am Heart J. 2008 Apr; 155(4):680-6. Epub 2008 Feb 21. PMID:18371476. DOI:10.1016/j.ahj.2007.11.007.
164. Long KH, Ting HH, McMurtry EK, Lennon RJ, Wood DL, Holmes DR Jr, Raveendran G, Rihal CS. A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3074 percutaneous coronary interventions. Value Health. 2008 May-Jun; 11(3):462-9. PMID:18489669. DOI:10.1111/j.1524-4733.2007.00257.x.
165. Vlaar PJ, Rihal CS, Singh M, Lennon R, Ting HH, Bresnahan JF, Holmes DR Jr. Safety and efficacy of drug-eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort. Catheter Cardiovasc Interv. 2008 May 1; 71(6):764-9. PMID:18412074. DOI:10.1002/ccd.21479.
166. Han SH, Bae JH, Holmes DR Jr, Lennon RJ, Eeckhout E, Barsness GW, Rihal CS, Lerman A. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J. 2008 Jun; 29(11):1359-69. Epub 2008 Apr 18. PMID:18424787. DOI:10.1093/eurheartj/ehn142.
167. Singh M, Rihal CS, Gersh BJ, Roger VL, Bell MR, Lennon RJ, Lerman A, Holmes DR Jr. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol. 2008 Jun 17; 51(24):2313-20. PMID:18549915. PMCID:2733245. NIHMS:105926. DOI:10.1016/j.jacc.2008.01.066.
168. Holmes DR Jr, Firth BG, Hodgson PK, Rihal CS, Wood DL, Cohen DJ. Evolving challenges in medical device evaluation. Catheter Cardiovasc Interv. 2008 Jul 1; 72(1):1-6. PMID:18546235. DOI:10.1002/ccd.21541.
169. Prasad A, Rihal C, Holmes DR Jr. The COURAGE trial in perspective. Catheter Cardiovasc Interv. 2008 Jul 1; 72(1):54-9. PMID:18412271. DOI:10.1002/ccd.21522.
170. Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR Jr. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008 Jul 8; 118(2):131-9. PMID:18591440. DOI:10.1161/CIRCULATIONAHA.107.738740.
171. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR Jr. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv. 2008 Aug; 1(1):10-9. PMID:20031650. DOI:10.1161/CIRCINTERVENTIONS.108.765610.
172. Fealey ME, Edwards WD, Giannini C, Piepgras DG, Cloft H, Rihal CS. Complications of endovascular polymers associated with vascular introducer sheaths and metallic coils in 3 patients, with literature review. Am J Surg Pathol. 2008 Sep; 32(9):1310-6. PMID:18636015. DOI:10.1097/PAS.0b013e318165582a.
173. Gumina RJ, Yang EH, Sandhu GS, Prasad A, Bresnahan JF, Lennon RJ, Rihal CS, Holmes DR Jr, Singh M. Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention. Mayo Clin Proc. 2008 Sep; 83(9):995-1001. PMID:18775199.
174. Nuttall GA, Brown MJ, Stombaugh JW, Michon PB, Hathaway MF, Lindeen KC, Hanson AC, Schroeder DR, Oliver WC, Holmes DR, Rihal CS. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology. 2008 Oct; 109(4):588-95. PMID:18813036. DOI:10.1097/ALN.0b013e318186ddf8.
175. Rabbitts JA, Nuttall GA, Brown MJ, Hanson AC, Oliver WC, Holmes DR, Rihal CS. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology. 2008 Oct; 109(4):596-604. PMID:18813037. DOI:10.1097/ALN.0b013e318186de1c.
176. Singh M, Alexander K, Roger VL, Rihal CS, Whitson HE, Lerman A, Jahangir A, Nair KS. Frailty and its potential relevance to cardiovascular care. Mayo Clin Proc. 2008 Oct; 83(10):1146-53. PMID:18828975. PMCID:2704096. NIHMS:114555.
177. Sorajja P, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Holmes DR Jr. Effect of septal ablation on myocardial relaxation and left atrial pressure in hypertrophic cardiomyopathy an invasive hemodynamic study. JACC Cardiovasc Interv. 2008 Oct; 1(5):552-60. PMID:19463358. DOI:10.1016/j.jcin.2008.07.004.
178. Singh M, Rihal CS, Roger VL, Lennon RJ, Spertus J, Jahangir A, Holmes DR Jr. Comorbid conditions and outcomes after percutaneous coronary intervention. Heart. 2008 Nov; 94(11):1424-8. Epub 2007 Oct 08. PMID:17923464. PMCID:2731585. NIHMS:105935. DOI:10.1136/hrt.2007.126649.
179. Bae JH, Kwon TG, Hyun DW, Rihal CS, Lerman A. Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study. Heart. 2008 Dec; 94(12):1559-64. Epub 2008 Apr 01. PMID:18381376. DOI:10.1136/hrt.2007.135822.
180. From AM, Rihal CS, Lennon RJ, Holmes DR Jr, Prasad A. Temporal trends and improved outcomes of percutaneous coronary revascularization in nonagenarians. JACC Cardiovasc Interv. 2008 Dec; 1(6):692-8. PMID:19463386. DOI:10.1016/j.jcin.2008.07.009.
181. Salisbury AC, Olalla-Gomez C, Rihal CS, Bell MR, Ting HH, Casaclang-Verzosa G, Oh JK. Frequency and Predictors of Urgent Coronary Angiography in Acute Pericarditis. Mayo Clinic Proceedings. 2009; 84(1):11-5.
182. Salisbury AC, Olalla-Gomez C, Rihal CS, Bell MR, Ting HH, Casaclang-Verzosa G, Oh JK. Frequency and predictors of urgent coronary angiography in patients with acute pericarditis. Mayo Clin Proc. 2009; 84(1):11-5. PMID:19121248. PMCID:2664564.
183. Dunlay SM, Rihal CS, Sundt TM, Gerber Y, Roger VL. Current trends in coronary revascularization. Curr Treat Options Cardiovasc Med. 2009 Feb; 11(1):61-70. PMID:19141262.
184. Mookadam F, Green J, Holmes D, Moustafa SE, Rihal C. Clinical relevance of myocardial bridging severity: single center experience. Eur J Clin Invest. 2009 Feb; 39(2):110-5. PMID:19200164. DOI:10.1111/j.1365-2362.2008.02073.x.
185. Park SM, Miyazaki C, Prasad A, Bruce CJ, Chandrasekaran K, Rihal C, Bell MR, Oh JK. Feasibility of prediction of myocardial viability with Doppler tissue imaging following percutaneous coronary intervention for ST elevation anterior myocardial infarction. J Am Soc Echocardiogr. 2009 Feb; 22(2):183-9. Epub 2009 Jan 01. PMID:19121567. DOI:10.1016/j.echo.2008.11.018.
186. Kataoka T, Mathew V, Rubinshtein R, Rihal CS, Lennon R, Lerman LO, Lerman A. Association of plaque composition and vessel remodeling in atherosclerotic renal artery stenosis: a comparison with coronary artery disease. JACC Cardiovasc Imaging. 2009 Mar; 2(3):327-38. PMID:19356579. PMCID:2941979. NIHMS:232238. DOI:10.1016/j.jcmg.2008.08.008.
187. Kiernan TJ, Boilson BA, Sandhu GS, Lennon RJ, Roger VL, Barsness GW, Lerman A, Rihal CS, Simari RD. Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: a population-based study in Olmsted County, Minnesota. Coron Artery Dis. 2009 Mar; 20(2):106-11. PMID:19225399. PMCID:2729703. NIHMS:94548. DOI:10.1097/MCA.0b013e3283239819.
188. Sloan KP, Bruce CJ, Oh JK, Rihal CS. Complications of echocardiography-guided endomyocardial biopsy. J Am Soc Echocardiogr. 2009 Mar; 22(3):324.e1-4. PMID:19258180. DOI:10.1016/j.echo.2008.12.023.
189. Srinivasan M, Rihal C, Holmes DR, Prasad A. Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes. Circulation. 2009 Mar 10; 119(9):1311-9. PMID:19273732. DOI:10.1161/CIRCULATIONAHA.108.831453.
190. Horst B, Rihal CS, Holmes DR Jr, Bresnahan JF, Prasad A, Gau G, Lennon R, Lerman A. Comparison of drug-eluting and bare-metal stents for stable coronary artery disease. JACC Cardiovasc Interv. 2009 Apr; 2(4):321-8. PMID:19463444. DOI:10.1016/j.jcin.2008.11.010.
191. Jaber WA, Yang EH, Nishimura RA, Sorajja P, Rihal CS, Elesber A, Eeckhout E, Lerman A. Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Heart. 2009 Apr; 95(7):564-9. Epub 2008 Oct 24. PMID:18952634. DOI:10.1136/hrt.2008.148239.
192. Raichlin E, Bae JH, Kushwaha SS, Lennon RJ, Prasad A, Rihal CS, Lerman A. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol. 2009 Apr 14; 53(15):1279-86. PMID:19358941. DOI:10.1016/j.jacc.2008.12.041.
193. Raichlin E, Kushwaha SS, Lennon RJ, Frantz RP, Edwards BS, Prasad A, Rihal CS, Lerman A. Features of cardiac allograft coronary endothelial dysfunction. Am J Cardiol. 2009 Apr 15; 103(8):1154-8. Epub 2009 Feb 28. PMID:19361606. DOI:10.1016/j.amjcard.2008.12.039.
194. Dib C, Asirvatham S, Elesber A, Rihal C, Friedman P, Prasad A. Clinical correlates and prognostic significance of electrocardiographic abnormalities in apical ballooning syndrome (Takotsubo/stress-induced cardiomyopathy). Am Heart J. 2009 May; 157(5):933-8. PMID:19376324. DOI:10.1016/j.ahj.2008.12.023.
195. Kim LJ, King SB 3rd, Kent K, Brooks MM, Kip KE, Abbott JD, Jacobs AK, Rihal C, Hueb WA, Alderman E, Sing IR, Attubato MJ, Feit F, BARI 2D (Bypass Angioplasty Revascularization Investigation Type 2 Diabetes) Study Group. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial. JACC Cardiovasc Interv. 2009 May; 2(5):384-92. PMID:19463459. DOI:10.1016/j.jcin.2009.01.009.
196. Rahim SA, Pitta SR, Rihal CS. Saphenous vein graft pseudoaneurysm. J Am Coll Cardiol. 2009 May 19; 53(20):1918. PMID:19442893. DOI:10.1016/j.jacc.2009.01.063.
197. Cassar A, Chareonthaitawee P, Rihal CS, Prasad A, Lennon RJ, Lerman LO, Lerman A. Lack of correlation between noninvasive stress tests and invasive coronary vasomotor dysfunction in patients with nonobstructive coronary artery disease. Circ Cardiovasc Interv. 2009 Jun; 2(3):237-44. Epub 2009 May 08. PMID:20031721. PMCID:2771952. NIHMS:126624. DOI:10.1161/CIRCINTERVENTIONS.108.841056.
198. Park SM, Prasad A, Rihal C, Bell MR, Oh JK. Left ventricular systolic and diastolic function in patients with apical ballooning syndrome compared with patients with acute anterior ST-segment elevation myocardial infarction: a functional paradox. Mayo Clin Proc. 2009 Jun; 84(6):514-21. PMID:19483168. PMCID:2688625. DOI:10.4065/84.6.514.
199. Raichlin E, Prasad A, Kremers WK, Edwards BS, Rihal CS, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients. Eur Heart J. 2009 Jun; 30(11):1356-63. Epub 2009 Apr 21. PMID:19383734. DOI:10.1093/eurheartj/ehp123.
200. Singh M, Gersh BJ, Lennon RJ, Ting HH, Holmes DR Jr, Doyle BJ, Rihal CS. Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience. Mayo Clin Proc. 2009 Jun; 84(6):501-8. PMID:19483166. PMCID:2688623. DOI:10.4065/84.6.501.
201. Doyle BJ, Rihal CS, Gastineau DA, Holmes DR Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol. 2009 Jun 2; 53(22):2019-27. PMID:19477350. DOI:10.1016/j.jacc.2008.12.073.
202. Rahim SA, Greason KL, Bjarnason H, Rihal CS. Left ventricular pseudoaneurysm. J Am Coll Cardiol. 2009 Aug 18; 54(8):740. PMID:19679254. DOI:10.1016/j.jacc.2009.02.087.
203. Lavi S, Bae JH, Rihal CS, Prasad A, Barsness GW, Lennon RJ, Holmes DR Jr, Lerman A. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart. 2009 Sep; 95(18):1525-30. Epub 2009 Jun 03. PMID:19497916. DOI:10.1136/hrt.2009.166017.
204. Madhavan M, Borlaug BA, Lerman A, Rihal CS, Prasad A. Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart. 2009 Sep; 95(17):1436-41. Epub 2009 May 24. PMID:19468013. DOI:10.1136/hrt.2009.170399.
205. Nestler DM, Noheria A, Haro LH, Stead LG, Decker WW, Scanlan-Hanson LN, Lennon RJ, Lim CC, Holmes DR Jr, Rihal CS, Bell MR, Ting HH. Sustaining improvement in door-to-balloon time over 4 years: the Mayo clinic ST-elevation myocardial infarction protocol. Circ Cardiovasc Qual Outcomes. 2009 Sep; 2(5):508-13. PMID:20031884. DOI:10.1161/CIRCOUTCOMES.108.839225.
206. Zhu XY, Zhang DZ, Han XM, Cui CS, Sheng XT, Wang QG, Cha YM, Abhiram P, Rihal CS. Transcatheter closure of congenital coronary artery fistulae: immediate and long-term follow-up results. Clin Cardiol. 2009 Sep; 32(9):506-12. PMID:19743489. DOI:10.1002/clc.20650.
207. Austin D, Oldroyd KG, Holmes DR Jr, Rihal CS, Galbraith PD, Ghali WA, Legrand V, Taeymans Y, McConnachie A, Pell JP, APPROACH Investigators, Belgian Working Group on Invasive Cardiology, Mayo Clinic PCI Registry, Scottish Coronary Revascularisation Registry. Drug-eluting stents: a study of international practice. Am Heart J. 2009 Oct; 158(4):576-84. PMID:19781417. DOI:10.1016/j.ahj.2009.07.033.
208. Gulati R, Rihal CS, Gersh BJ. The SYNTAX trial: a perspective. Circ Cardiovasc Interv. 2009 Oct; 2(5):463-7. PMID:20031757. DOI:10.1161/CIRCINTERVENTIONS.109.882670.
209. Booker JD, Rihal CS. Current Management of Paravalvular Regurgitation. Cardiac Intvn Today, submitted. Nov. 2009.
210. Ford MA, McConnell JP, Lavi S, Rihal CS, Prasad A, Sandhu GS, Hartman SJ, Lerman LO, Lerman A. Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy. Atherosclerosis. 2009 Nov; 207(1):111-5. Epub 2009 May 06. PMID:19515370. PMCID:2783869. NIHMS:115636. DOI:10.1016/j.atherosclerosis.2009.04.039.
211. Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ, EVENT Registry Investigators. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. JACC Cardiovasc Interv. 2009 Nov; 2(11):1074-82. PMID:19926047. DOI:10.1016/j.jcin.2009.09.002.
212. Schultz JC, Hilliard AA, Cooper LT Jr, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc. 2009 Nov; 84(11):1001-9. PMID:19880690. PMCID:2770911. DOI:10.4065/84.11.1001.
213. Cassar A, Holmes DR Jr, Rihal CS, Gersh BJ. Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc. 2009 Dec; 84(12):1130-46. PMID:19955250. PMCID:2787400. DOI:10.4065/mcp.2009.0391.
214. Hlatky MA, Boothroyd DB, Melsop KA, Kennedy L, Rihal C, Rogers WJ, Venkitachalam L, Brooks MM, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Circulation. 2009 Dec 22; 120(25):2550-8. Epub 2009 Nov 17. PMID:19920002. DOI:10.1161/CIRCULATIONAHA.109.912709.
215. Hagler DJ, Cabalka AK, Sorajja P, Cetta F, Mankad SV, Bruce CJ, Sinak LJ, Chandrasekaran K, Rihal CS. Assessment of percutaneous catheter treatment of paravalvular prosthetic regurgitation. JACC Cardiovasc Imaging. 2010 Jan; 3(1):88-91. PMID:20129537. DOI:10.1016/j.jcmg.2009.10.010.
216. Hilliard AA, From AM, Lennon RJ, Singh M, Lerman A, Gersh BJ, Holmes DR Jr, Rihal CS, Prasad A. Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents. JACC Cardiovasc Interv. 2010 Feb; 3(2):172-9. PMID:20170874. DOI:10.1016/j.jcin.2009.11.013.
217. Rubinshtein R, Yang EH, Rihal CS, Prasad A, Lennon RJ, Best PJ, Lerman LO, Lerman A. Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur Heart J. 2010 Apr; 31(8):936-42. Epub 2009 Nov 05. PMID:19897496. PMCID:2854505. DOI:10.1093/eurheartj/ehp459.
218. Takumi T, Yang EH, Mathew V, Rihal CS, Gulati R, Lerman LO, Lerman A. Coronary endothelial dysfunction is associated with a reduction in coronary artery compliance and an increase in wall shear stress. Heart. 2010 May; 96(10):773-8. PMID:20448128. DOI:10.1136/hrt.2009.187898.
219. *From AM, Al Badarin FJ, Cha SS, Rihal CS. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis of data from the ARTS II, CARDia, ERACI III, and SYNTAX studies and systematic review of observational data. EuroIntervention. 2010 Jun; 6(2):269-76. PMID:20562080. DOI:10.4244/.
220. Pulido JN, Park SJ, Rihal CS. Percutaneous left ventricular assist devices: clinical uses, future applications, and anesthetic considerations. J Cardiothorac Vasc Anesth. 2010 Jun; 24(3):478-86. Epub 2010 Jan 06. PMID:20056444. DOI:10.1053/j.jvca.2009.10.026.
221. Spoon DB, Lerman A, Rule AD, Prasad A, Lennon RJ, Holmes DR, Rihal CS. The association of serum uric acid levels with outcomes following percutaneous coronary intervention. J Interv Cardiol. 2010 Jun; 23(3):277-83. PMID:20636849. DOI:10.1111/j.1540-8183.2010.00555.x.
222. Cassar A, Poldermans D, Rihal CS, Gersh BJ. The management of combined coronary artery disease and peripheral vascular disease. Eur Heart J. 2010 Jul; 31(13):1565-72. Epub 2010 Jun 05. PMID:20525983. DOI:10.1093/eurheartj/ehq186.
223. Holmes DR Jr, Aguirre FV, Aplin R, Lennon RJ, Nestler DM, Bell MR, Rihal CS, Ting HH. Circadian rhythms in patients with ST-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2010 Jul; 3(4):382-9. Epub 2010 Jun 22. PMID:20570918. DOI:10.1161/CIRCOUTCOMES.109.913343.
224. Gossl M, Rihal CS. Cardiac shunt calculations made easy: a case-based approach. Catheter Cardiovasc Interv. 2010 Jul 1; 76(1):137-42. PMID:20578099. DOI:10.1002/ccd.22471.
225. From AM, Al Badarin FJ, McDonald FS, Bartholmai BJ, Cha SS, Rihal CS. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials. Circ Cardiovasc Interv. 2010 Aug; 3(4):351-8. Epub 2010 Jul 20. PMID:20647563. DOI:10.1161/CIRCINTERVENTIONS.109.917070.
226. Rihal CS, Ryan JL, Singh M, Lennon RJ, Bresnahan JF, Liesinger JT, Gersh BJ, Ting HH, Holmes DR Jr, Long KH. Clinical and economic outcomes after introduction of drug-eluting stents. Am J Manag Care. 2010 Aug; 16(8):580-7. PMID:20712391.
227. Konecny T, Somers K, Orban M, Koshino Y, Lennon RJ, Scanlon PD, Rihal CS. Interactions between COPD and outcomes after percutaneous coronary intervention. Chest. 2010 Sep; 138(3):621-7. Epub 2010 Apr 09. PMID:20382719. DOI:10.1378/chest.10-0300.
228. Srinivasan M, Rihal CS, Singh M, Lennon RJ, Holmes DR, Prasad A. Percutaneous coronary intervention in native vessels with angiographically visible thrombus temporal trends and impact of drug-eluting stents. JACC Cardiovasc Interv. 2010 Sep; 3(9):937-46. PMID:20850093. DOI:10.1016/j.jcin.2010.06.013.
229. Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, Lennon R, Rihal C, Lerman LO, Lerman A. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation. 2010 Sep 7; 122(10):958-66. Epub 2010 Aug 23. PMID:20733096. PMCID:2946239. NIHMS:229267. DOI:10.1161/CIRCULATIONAHA.110.967406.
230. Singh M, Holmes DR, Lennon RJ, Rihal CS. Development and validation of risk adjustment models for long-term mortality and myocardial infarction following percutaneous coronary interventions. Circ Cardiovasc Interv. 2010 Oct; 3(5):423-30. Epub 2010 Oct 05. PMID:20923988. DOI:10.1161/CIRCINTERVENTIONS.109.924308.
231. Veress G, Bruce CJ, Kutzke K, Click RL, Scott CG, Oh JK, Rihal CS. Acute thrombus formation as a complication of right ventricular biopsy. J Am Soc Echocardiogr. 2010 Oct; 23(10):1039-44. PMID:20868954. DOI:10.1016/j.echo.2010.07.006.
232. From AM, Best PJ, Lennon RJ, Rihal CS, Prasad A. Acute myocardial infarction due to left circumflex artery occlusion and significance of ST-segment elevation. Am J Cardiol. 2010 Oct 15; 106(8):1081-5. PMID:20920642. DOI:10.1016/j.amjcard.2010.06.016.
233. Martin EA, Prasad A, Rihal CS, Lerman LO, Lerman A. Endothelial function and vascular response to mental stress are impaired in patients with apical ballooning syndrome. J Am Coll Cardiol. 2010 Nov 23; 56(22):1840-6. PMID:21087714. DOI:10.1016/j.jacc.2010.03.107.
234. Gossl M, Modder UI, Gulati R, Rihal CS, Prasad A, Loeffler D, Lerman LO, Khosla S, Lerman A. Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur Heart J. 2010 Dec; 31(23):2909-14. Epub 2010 Oct 08. PMID:20935001. PMCID:2995953. DOI:10.1093/eurheartj/ehq373.
235. From AM, Gulati R, Prasad A, Rihal CS. Sheathless transradial intervention using standard guide catheters. Catheter Cardiovasc Interv. 2010 Dec 1; 76(7):911-6. Epub 2010 Oct 07. PMID:20824748. DOI:10.1002/ccd.22742.
236. Pitta SR, Cabalka AK, Rihal CS. Complications associated with left ventricular puncture. Catheter Cardiovasc Interv. 2010 Dec 1; 76(7):993-7. Epub 2010 Oct 06. PMID:20928838. DOI:10.1002/ccd.22640.
237. Mookadam F, Carpenter SD, Thota VR, Cha S, Jiamsripong P, Alharthi MS, Rihal CS, Abel MD. Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery. Future Cardiol. 2011 Jan; 7(1):69-75. PMID:21174512. DOI:10.2217/fca.10.116.
238. Mahmoud KD, de Smet BJ, Zijlstra F, Rihal CS, Holmes DR Jr. Sudden cardiac death: epidemiology, circadian variation, and triggers. Curr Probl Cardiol. 2011 Feb; 36(2):56-80. PMID:21356429. DOI:10.1016/j.cpcardiol.2011.01.002.
239. Mahmoud KD, Lennon RJ, Ting HH, Rihal CS, Holmes DR Jr. Circadian variation in coronary stent thrombosis. JACC Cardiovasc Interv. 2011 Feb; 4(2):183-90. PMID:21349457. DOI:10.1016/j.jcin.2010.09.025.
240. Fetterly KA, Lennon RJ, Bell MR, Holmes DR Jr, Rihal CS. Clinical determinants of radiation dose in percutaneous coronary interventional procedures: influence of patient size, procedure complexity, and performing physician. JACC Cardiovasc Interv. 2011 Mar; 4(3):336-43. PMID:21435613. DOI:10.1016/j.jcin.2010.10.014.
241. Khawaja FJ, Rihal CS, Lennon RJ, Holmes DR, Prasad A. Temporal trends (over 30 years), clinical characteristics, outcomes, and gender in patients ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
Related searches
- curriculum vitae template word document
- curriculum vitae finance manager sample
- curriculum vitae format in word
- curriculum vitae sample doc
- curriculum vitae sample pdf
- curriculum vitae samples for teachers
- curriculum vitae template free download
- curriculum vitae template word download
- nursing curriculum vitae template pdf
- best curriculum vitae format
- curriculum vitae en francais modele
- curriculum vitae examples word